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Host responsiveness to IFN is critical for resolution of Listeria infection, but the
identities and roles of IFN responsive cells that initiate this process remain unclear. In
this thesis, unique mice displaying conditional loss of the IFN receptor (Ifngr1f/f mice) in
different tissues have been generated and used to explore the role of this cytokine in
initiating the anti-Listeria response.
Whereas Ifngr1f/f mice displayed normal cellular levels of IFNGR1 and normal
resistance to Listeria infection, Vav-icre+Ifngr1f/f mice lacking IFN responsiveness
selectively in hematopoietic cells exhibited highly increased susceptibility to Listeria
infection comparable to that of Ifngr1-/- mice. In contrast, Itgax-cre+ Ifngr1f/f mice lacking
IFN responsiveness selectively in dendritic cells expressing CD8 and/or CD103
displayed increased susceptibility to Listeria infection. This phenotype was traced back to
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a defect in the capacity of IFN unresponsive CD8+ DCs to produce IL-12. The IFN
required for priming CD8+ DCs for optimal IL-12 production is derived from TNFactivated NK/NKT cells. These mice survived Listeria infection due to a second wave of
IL-12 produced by other myeloid cells.
Next, Ifngr1f/f mice were bred with LysM-cre mice to obtain myeloid cell specific
Ifngr1 deletion. LysM-cre+Ifngr1f/f mice lacking IFN responsiveness selectively in both
peritoneal macrophages and neutrophils succumbed to Listeria infection. Surprisingly,
adoptively transferred WT neutrophils into LysM-cre+Ifngr1f/f mice seemed to completely
rescue LysM-cre+Ifngr1f/f mice whereas Ifngr1-/- neutrophils did not. Thus, these results
reveal that neutrophils are also one of the important targets of IFN for Listeria resolution.
This study thus demonstrates an early acting, IFN driven cytokine and cellular
cascade involving NK/NKT and CD8+ DCs leads to rapid production of IL-12 that
ultimately leads to activation of myeloid cells including macrophages and neutrophils in
IFN-rich cytokine environment.
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CHAPTER 1
Introduction

IFN is crucial for immunity against intracellular bacterial pathogens such as
Listeria Monocytogenes. IFN coordinates a large array of immunological responses
through transcriptional regulation of genes which are relevant to both innate and adaptive
immunities. IFN mediated cellular responses are integrated with other pathogen
associated cytokines, such as TNF and IL-12. Cellular effects of IFN include pathogen
recognition, promotion of antigen processing and presentation, regulation of cellular
proliferation and apoptosis, induction of microbicidal effector functions, and direction of
leukocyte trafficking. However, it remains to be addressed which components of the
innate, adaptive or non-hematopoietic compartments require IFN sensitivity in order to
resolve Listeria infection.

Type II interferon (IFN)
Interferons (IFNs) were originally described as cytokines capable of protecting
host cells from pathogens (Farrar and Schreiber, 1993). The members of IFNs have been
divided into two different groups based on their cellular source, genetic structure, and
biological activities. Type I IFN is induced primarily by viral infection of cells and has
been subdivided into two classes, IFN and IFN. In contrast, Type II IFN is induced by
various pro-inflammatory stimuli and consists of a single member, IFN. IFN has no
genetic and structural similarity with Type I IFNs; IFN is located in different
1

chromosome and its protein structure is distinct from that of IFN and IFN. The
crystallography of IFN confirmed its dimeric structure which is associated in an
antiparallel orientation (Ealick et al., 1991).
IFN binds to a distinct cell surface receptor, IFN receptor (IFNGR) and
primarily signals through the JAK-STAT pathway, a pathway used by various cytokines,
growth hormones, and hormones to regulate gene expression (Bach et al., 1997).
Functional IFN receptor is composed of a ligand binding subunit, IFNGR1, and a signal
transducing subunit IFNGR2. IFNGR1 is constitutively expressed on the surface of
nearly all types of cells whereas IFNGR2 appears to be expressed at extremely low levels
and regulated by external stimuli. We previously demonstrated that the IFN
unresponsiveness in a subset of T cells (Th1) is due to a lack of cellular expression of
IFNGR2 (Bach et al., 1995). Thus, the regulation of IFNGR2 gene becomes a limiting
factor for IFN responsiveness in certain cells. The human IFNGR1 is encoded by a 30kb
gene located on chromosome 6 (Aguet et al., 1988), while the murine homologue is a
22kb gene present on chromosome 10 (Gray et al., 1989; Hemmi et al., 1989). The
human IFNGR2 has been localized to chromosome 21 and the murine homologue resides
on chromosome 16 (Hemmi et al., 1994; Soh et al., 1994).
Neither IFNGR chains have intrinsic kinase/phosphatase activity. Thus, the
intracellular domain of IFNGR1 has a 266LPKS269 binding motif for the Janus tyrosine
kinase 1 (JAK1), and the IFNGR2 intracellular region contains a binding motif
(263PPSIPLQIEEYL274) for JAK2 (Bach et al., 1996; Greenlund et al., 1994). Both
IFNGR subunits are constitutively associated with inactive form of JAKs through their
2

motifs. The binding of IFN, a homo-dimeric ligand, to the cells in 2:2 stoichiometry
induces assembly of the complete receptor complex containing two IFNGR1 and two
IFNGR2. In this complex, JAK2 is auto-phosphorylated/activated and JAK1 is
subsequently phosphorylated by activated JAK2. The activated JAK1 phosphorylates a
key tyrosine residue (Y440) of 440YDKPH444 motif within the cytoplasmic domain of
each IFNGR1 to form two docking site for the SH2 domains of STAT1 (Farrar et al.,
1992; Greenlund et al., 1994). Two STAT1 molecules are then brought into close
proximity with receptor-associated activated JAK enzymes. The receptor recruited
STAT1 pair is phosphorylated at Y701 probably by JAK2, leading STAT1 dimerization
and dissociation from the receptor. The dissociated STAT1 homodimer translocates into
the nucleus and binds to transcriptional regulatory elements such as IFN activation site
(GAS) element to initiate or suppress transcription of IFN-regulated genes. The gene
transcription induced by IFN occurs within 15-30 minutes of IFN treatment (Kerr and
Stark, 1991). Many genes induced by IFN are in fact transcription factors including
IRF1 which is able to initiate the second wave of transcription.
IFN effects on a wide range of target cells, and its pleiotropic actions have been
well studied (Farrar and Schreiber, 1993). These include various host defense
mechanisms against infectious agents and tumor development. IFN can exert
antiproliferative effects on a variety of normal and neoplastic cells. IFN is also
acknowledged to play an immune-regulatory roles. IFN is one of the major cytokines
responsible for enhancing antigen processing and presentation in part by up-regulating
MHC class I expression and inducing MHC class II on antigen presenting cells. IFN has
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also been shown to be the major cytokine responsible for activating mononuclear
phagocytes to clear pathogens. In addition, IFN regulates antibody responses by
modulating Ig class switching recombination. Finally, IFN regulates the production of a
variety of other immune-regulatory or pro-inflammatory cytokines such as IL-12 and
TNF.

Listeria Monocytogenes
Listeria monocytogenes is a gram-positive intracellular bacterium that can cause
significant disease in neonates, the elderly, and immunocompromised individuals (Pamer,
2004). As a food-borne pathogen, the natural route of Listeria infection is through the
gastrointestinal tract. Listeria is capable of invading intestinal epithelial cells by inducing
cytoskeletal changes and membrane extensions (Cossart and Lecuit, 1998). This
‘engulfing’ requires the interaction between internalin A on the surface of Listeria and Ecadherin on the surface of epithelial cells. Mice are relatively more resistant to intestinal
Listeria infection than humans because of a particular amino acid difference between
human (Pro16) and mouse E-cadherin (Glu16) renders the murine form of the protein
insensitive to internalin A-mediated invasion (Lecuit et al., 2001). Once Listeria invades
the epithelial layer, they are rapidly disseminated into spleen and liver through the blood
stream. In the liver, Listeria infects hepatocytes through the interaction of internalin B
and the Met receptor tyrosine kinase that is expressed at the surface of hepatocytes (Shen
et al., 2000). In spleen and liver, Listeria is rapidly internalized by splenic and hepatic
phagocytes. After entering the phagosomes, Listeria penetrates the vacuolar membrane
4

and enters the cytoplasm through secreting listeriolysin O (LLO), the pore forming toxin
(Bielecki et al., 1990). LLO-mediated invasion of the cytosol is important to induce
protective immunity because LLO deficient strain of Listeria fails to induce a protective
T cell mediated response (Berche et al., 1987). In the cytoplasm, Listeria proliferates and
induces actin polymerization by expressing actin assembly inducing protein (ActA) in a
polarized manner, which generates bacterial movement and finally causes cell-to-cell
infection spreading (Tilney and Portnoy, 1989).

Immunity to Listeria infection
The mouse model of Listeria infection has been extensively studied for
understanding the mechanisms of host resistance to an intracellular pathogen. Since
George Mackaness first developed the systemic murine infection model for Listeria
(Mackaness, 1962), most studies of Listeria infection have used either intraperitoneal or
intravenous inoculation of bacteria. Thus, our current knowledge of immune responses
against Listeria infection is mostly based on systemic infection although the natural route
of Listeria infection is ingestion of bacteria and subsequent uptake of them by intestinal
epithelial cells.
The innate immune response to Listeria involves a complex interaction of
various cytokines and innate immune cells such as macrophages. By using a neutralizing
mAb for IFN, the activation of macrophages by IFN was shown to be critical for in vivo
clearance of bacteria from the infected animal (Buchmeier and Schreiber, 1985). The

importance and effectiveness of innate immunity to Listeria infection was further proven
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using SCID (Severe combined immunodeficiency) mice (Bancroft et al., 1989; Edelson
and Unanue, 2000). Mice which are devoid of T and B cells were shown to be
surprisingly effective in controlling initial Listeria infection although the complete
sterilization of bacterial infection requires adaptive immunity. Subsequent studies using
SCID mice revealed that NK cells were responsible for early production of IFN and that
the IFN produced by NK cells activated microbicidal activity in macrophages thus
providing the host with a rapid ability to control the initial stages of Listeria infection
(Bancroft et al., 1989; Tripp et al., 1993; Wherry et al., 1991). This observation
stimulated mechanistic studies that employed neutralizing/depleting antibodies and genetargeted mice to define many of the components of innate immunity that participates in
the early host response to Listeria (Bancroft et al., 1989; Brombacher et al., 1999; Dunn
and North, 1991; Tripp et al., 1994). For example, activation of macrophages is clearly
critical for immunity to Listeria because antibody-mediated neutralization/genetic
ablation of IFN/IFNR or pharmacological inhibition/genetic ablation of iNOS
(inducible nitric oxide synthase) and NADPH oxidase results in markedly increased
susceptibility to Listeria infection (Buchmeier and Schreiber, 1985; Dalton et al., 1993;
Huang et al., 1993; Shiloh et al., 1999).
Still other studies revealed that IFN is produced throughout the course of
infection and plays a key role in driving the development and effector functions of the
Type I T cell response (Th1 CD4+ T cells and CD8+ T cells) responsible for development
of the sterilizing immunity (Macatonia et al., 1993; Szabo et al., 1997). Together this
work resulted in a detailed understanding of the molecular and cellular events that occur
6

during host responses to Listeria infection (Unanue, 1997). Early in infection, low levels
of TNF and IL-12 are thought to stimulate production of low levels of IFN by NK cells.
This early-appearing IFN then activates microbicidal activity in macrophages thereby
providing the host with a mechanism to control infection until sterilizing, adaptive
immunity can develop. Subsequently, the IFN- and IL-12-rich cytokine environment
promotes induction of a Type I T cell response that produces even more IFN and
induces the cellular effector functions needed to produce sterilizing immunity to the
bacteria.
Although early resistance to Listeria infection is largely attributed to the
production of TNF and IL-12 by macrophages resulting in initial production of IFN, it
should be noted that the previous studies were largely based on macrophages which were
obtained from a lavage of SCID mouse peritoneal cavities. It is now clear that within a
few minutes of infection, Listeria is taken up by various phagocytic cells in spleen and
other organs (Waite et al., 2011). In the spleen, blood-borne pathogens are filtered out of
blood stream by resident cells in the marginal zone and red pulp (Aoshi et al., 2009).
Splenic resident phagocytes include marginal zone macrophages, metallophilic marginal
zone macrophages, neutrophils, F4/80+ red pulp macrophages, CD8+ dendritic cells, and
CD4+ dendritic cells. Therefore, with regards to the production of TNF and IL-12 in
vivo, it remains incompletely understood which one(s) among various resident
phagocytes is the major producer of these cytokines.

7

IFN for Listeria resolution
Early production of IFN in the host is crucial for the timely resolution of
Listeria infection, as demonstrated by studies using a neutralizing antibody to IFN
(Buchmeier and Schreiber, 1985)
(Dalton et al., 1993), IFNGR1 - the major ligand binding chain of the IFN receptor
(Huang et al., 1993), or STAT1, the major transcription factor that mediates IFN
receptor signaling (Goldszmid et al., 2012; Meraz et al., 1996). However, both the in vivo
cellular sources of IFN and in particular the IFN-responsive cells that initiate and
regulate protective responses have been difficult to identify.
NK cells have been thought to be the major producer of IFN after Listeria
infection (Unanue, 1997). IFN production by NK cells can be stimulated by several
cytokines including TNF from macrophages in combination with IL-12 (Tripp et al.,
1993), trans-presented IL-15 by dendritic cells (Lucas et al., 2007), and Type I IFN
(Biron et al., 1999). Humann and Lenz demonstrated that the activation of NK cells in
Listeria-infected mice depends on IL-18 as well as IL-12 (Humann and Lenz, 2010).
Direct contact between DC and NK cells is also required for priming NK cells, resulting
in enhanced cytotoxicity and IFN production (Andrews et al., 2003; Gerosa et al., 2002).
The spatiotemporal analysis of potential NK and DC interactions in Listeria-infected
spleens showed that CD11c+ DCs orchestrate the clustering of CD11b+ myeloid cells into
periarteriolar lymphoid sheaths (PALS) and the recruitment of NK cells to the outer
edges of these clusters where the production of IL-12 and IL-18 was detected (Kang et al.,
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2008). Hence, it seems probable that contact with Listeria-infected DCs directly activates
NK cells to produce IFN in PALS.
Memory CD8+ T cells are another viable candidate as an important source of
IFN. Berg et al. first demonstrated that memory CD8+ T cells have the potential to
secrete IFN after Listeria infection without TCR engagement in a few days of infection
(Berg et al., 2003, 2005). One study which used a Salmonella Typhimurium infection
model demonstrated that activation of inflammasomes leads to the release of IL-18 by
CD8+ DCs, which directly induces memory CD8+ T cells to produce IFN (Kupz et al.,
2012). Finally, splenic CD8+ DCs themselves were also reported as a potential source of
IFN in response to Listeria infection in the absence of NK cells (Ohteki et al., 1999).
In contrast to defining the sources of IFN, it has been particularly difficult to
identify the IFN responsive cells that are responsible for initiating the anti-Listeria
response since nearly every cell in the host expresses an IFN receptor (Bach et al., 1997).
It is likely that there are many direct cellular targets of IFN that participate in the antiListeria response (Schroder et al., 2004). An early study used radiation bone marrow
(BM) chimera approaches to demonstrate that IFN receptor (IFNR) expression in the
hematopoietic compartment was required for resistance to Listeria infection (Yap and
Sher, 1999). This initial demonstration prompted attempts to identify the in vivo targets
of the antibacterial actions of IFN. Because macrophages are known critical targets of
IFN, the Schreiber lab generated transgenic mice in which a dominant negative IFN
receptor mutant (IFNGR1.IC) was targeted to resident peritoneal macrophages using the
human lysozyme promoter and identified a subset of macrophages that were key
9

mediators of the IFN-dependent anti-Listeria response (Dighe et al., 1995). Recently, a
study using transgenic mice that express IFNGR1.IC in CD68+ cells showed the
additional importance of IFN-mediated macrophage activation for control of
Toxoplasma gondii infection (Lykens et al., 2010). These studies validate the use of
transgenic mice as a means of selectively eliminating IFN responsiveness in
macrophages. Additional studies in which specific tissues are rendered IFNunresponsive could provide valuable insight into the mechanisms underlying control of
intracellular pathogens. However, the use of tissue targeted overexpression of dominant
negative IFNGR1 mutants is not an ideal approach since extremely high expression of the
mutant receptor is required in order to suppress normal signaling by the wild type IFNR
(Dighe et al., 1995).

Subsets of murine dendritic cells
Since Ralph Steinman first identified dendritic cells as potent immune cells
which are involved in the induction of immune responses (Steinman and Cohn, 1973),
numerous studies support the idea that dendritic cells are extremely efficient antigen
presenting cells. For example, after CD11c (itgax; integrin alpha X) was identified as
DC-selective marker (Metlay et al., 1990), the generation of CD11c-DTR mice which
depletes DCs relatively selectively by single injection of diphtheria toxin was used to first
demonstrate that the priming of anti-Listeria immunity depends on CD11c+ dendritic cells
(Kang et al., 2008).
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DCs in mouse secondary lymphoid organs can be subdivided into two groups,
conventional DCs (cDC) and plasmacytoid DCs (pDCs). One of the key roles of pDCs is
the production of Type I IFN. It remains unclear whether pDCs perform an antigen
presentation function (Villadangos and Young, 2008). Conventional DCs can be
subdivided into resident DCs and migratory DCs. Resident DCs can be further
categorized into three subsets on the basis of their expression of CD4 and CD8, namely
CD4+ DCs, CD8+ DC, and double negative DCs (Vremec et al., 2000). Many studies
have led to the concept that lymphoid organ resident CD8+ DCs are specialized for
cross-presenting antigen (Heath and Carbone, 2009). When purified DC subsets from
Listeria-infected mice were incubated with antigen-specific CD8+ T cells, CD8+ DC
were the only cells that cross-presented antigens to prime naïve CD8+ T cells (Belz et al.,
2005). Recently, Hildner et al. generated Batf3-deficent mice that lacked lymphoidresident CD8+ DCs (and also CD103+ DCs) without other abnormalities (Hildner et al.,
2008). As expected, Batf3-deficent mice were not capable of cross-presenting antigens
and priming CD8+ T cell responses to tumor antigens and intracellular pathogens such as
West Nile and Sendai viruses in vivo.
Migratory DCs in dermis are currently divided into at least three distinct subsets,
Langerhans cells, CD103+CD11b-Langerin+ DCs, and CD103-CD11b+ Langerin- DCs.
Recent data described the existence of CD103+CD11b- DCs and CD103-CD11b+ DCs in
most peripheral organs including lung, liver, and kidney (Ginhoux et al., 2009). Since
Langerhans cells were the first DCs to be observed in skin sections by Paul Langerhans
(Romani et al., 2003), they were thought to have the classical phenotype of DCs.
11

However, after careful analysis of the function and location of langerin-expressing DCs,
three independent groups identified a novel subset of DCs that is langerin positive and
distinct from Langerhans cells and CD11b+ dermal DCs (Bursch et al., 2007; Ginhoux et
al., 2007; Poulin et al., 2007). Extensive characterization of this novel dermal DC
population showed that they were bone marrow derived, radio-sensitive and expressed
the CD103 integrin and were therefore distinct from classical radio-resistant Langerhans
cells,. Most importantly, CD103+ DCs are capable of migrating from peripheral tissues
such as skin to secondary lymphoid tissues and cross-presenting antigen (del Rio et al.,
2007; GeurtsvanKessel et al., 2008). Thus, the migratory CD103+ DCs and the lymphoid
tissue-resident CD8+ DCs have phenotypic and functional similarities including
expression of langerin, absence of CD11b expression, and the capacity to cross-present
antigens to prime CD8+ T cell responses.

Importance of dendritic cells during Listeria infection
Recently, much attention has focused on the role of dendritic cells (DCs) in the
development of Listeria infection. DCs are the primary cell type that senses, ingests, and
presents exogenous antigens from pathogens to initiate the adaptive immune response.
CD8+ DCs appear more potent than other DC subsets in processing and cross-presenting
exogenous antigens on surface MHC class I (Belz et al., 2005; Dudziak et al., 2007; Jung
et al., 2002). Their efficiency in cross-presentation is partly due to the delayed
phagosomal acidification relative to other phagocytes such as neutrophils, macrophages,
and other DC subsets (Savina et al., 2009). Conceivably, this delay helps CD8+ DCs
12

maintain higher antigen levels for cross-presentation, resulting in increased susceptibility
of CD8+ DCs to pathogens. Actually, Listeria was shown to exploit this intrinsic
susceptibility of CD8+ DCs as part of bacterial propagation in spleen. The studies using
CD11c-DTR mice revealed that mice depleted of CD11c+ cells lack productive Listeria
infection in the spleen (Kang et al., 2008; Neuenhahn et al., 2006). Furthermore, using
Batf3-/- mice, that selectively lack CD8+ DCs, it was possible to demonstrate this subset
of DCs was required for establishing Listeria infection in the spleen (Edelson et al., 2011;
Hildner et al., 2008). These findings support a scenario in which migratory CD8+ DCs
carry Listeria from their entry point in the splenic marginal zone to the T cell-rich PALS,
where Listeria then multiply in the ensuing 12-24 hours (Aoshi et al., 2008; Muraille et
al., 2005). In addition, Edelson et al. demonstrated that hepatic resistance to Listeria
infection is due to the absence of hepatic CD103+ DCs in Batf3-/- mice. Perhaps CD103+
DCs in hepatic sinusoids efficiently capture Listeria and transport them into the hepatic
parenchyma for productive liver infection.
Another important role of CD8+ DCs has been reported to be regulating
hierarchical clustering/activation of innate cells such as NK cells, neutrophils, and
monocytes (Kang et al., 2008). By challenging mice having a CD11c-cre transgene and a
diphtheria toxin A gene downstream of a flox-stop-flox into ROSA26 locus with Listeria,
Kang et al. showed in vivo depletion of DCs completely abrogated innate cell clustering
and subsequent cytokine production such as IL-12 and IFN around infection foci in the
white pulps of spleen. Therefore, CD8+ DCs facilitate the entry and expansion of
Listeria within clusters of innate cells in PALS. The precise mechanism by which CD8+
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DCs coordinate innate cell clustering at early times after infection remains to be defined.
It is not clear whether the complete abrogation of innate cell clustering in CD11c-DTR
mice is due to the absence of CD8+ DCs or merely the absence of Listeria infection
caused by depletion of essential bacterial carriers, CD8+ DCs.

Interleukin-12 for Listeria resolution
IL-12 is a heterodimer formed by a 35-kDa light chain (p35/IL-12) and a 40kDa heavy chain (p40/IL-12). Recently, it was found that p40 associates not only with
p35 to form IL-12, but also with p19 to form a new heterodimeric cytokine known as IL23 (Oppmann et al., 2000). The IL-12 receptor is composed of two polypeptides, IL12R1 and IL-12R2. The IL-12R2 subunit functions as a signal-transducing
component, which induces the phosphorylation and activation of Janus family kinase
JAK2 and TYK2. Activated JAK2 and TYK2 were shown to phosphorylate STAT1, 3, 4,
and 5 (Presky et al., 1996). However, the specific cellular effects of IL-12 are due mainly
to its activation of STAT4 because STAT4 deficient mice showed the identical phenotype
to mice which lack IL-12p40 (Thierfelder et al., 1996).
Interleukin-12 (IL-12) was first described independently as a potent NK
activating factor and cytotoxic lymphocyte maturation factor (Kobayashi et al., 1989;
Stern et al., 1990). It has since been extensively studied for its pro-inflammatory ability
to stimulate IFNproduction from NK cells and T cells and its immune-regulatory ability
to promote the development of the Th1 response (Chan et al., 1991; Hsieh et al., 1993).
The importance of IL-12 as an IFN inducer has been appreciated not only in its high
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efficiency even in low concentration, but also in its synergy with other stimulatory factors
such as IL-2, TCR engagement, and TNF(Chan et al., 1992; Chan et al., 1991). In
addition, IL-12 also regulates the contraction phase of CD8+ T cell response and the
generation of memory response (Pearce and Shen, 2007; Takemoto et al., 2006).
IL-12 is essential for resistance to sublethal doses of Listeria by inducing optimal
IFN production in NK cells (Brombacher et al., 1999; Tripp et al., 1994). IL-12p35-/mice showed increases in the number and size of granulomatous lesions even at low
doses of Listeria (≤ 1000 organisms). DCs and phagocytes including monocytes,
macrophages, and neutrophils are the main producers of IL-12 in response to microbial
stimulation (Trinchieri, 2003). However, in vivo depletion of resident cDC using CD11cDTR prior to Toxoplasma gondii infection has been shown to significantly reduce
systemic IL-12 production (Liu et al., 2006). A subsequent study using Batf3-/- mice
which genetically lack CD8+ DCs demonstrated that resident CD8+ DCs are the main
producers of IL-12 at least in T.gondii infection (Mashayekhi et al., 2011).
CD11c+MHCII+ DCs derived from Ly6C+ inflammatory monocytes were recently also
shown to be another source of IL-12 after T.gondii infection, and this production of IL-12
depends on IFN from NK cells (Goldszmid et al., 2012). In Listeria infection, both
resident CD8+ DCs and monocyte-derived DCs were shown to produce IL-12 (Kapadia
et al., 2011; Mitchell et al., 2011; Zhan et al., 2010). Although both resident CD8+ DCs
and monocyte-derived DCs can produce IL-12 during Listeria infection, the temporal
relationship of their participation in in vivo IL-12 production has, until now, not been
studied.
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Importance of neutrophils during Listeria infection
Neutrophils have long been thought to be an important innate cell for clearance
of Listeria, appearing at sites of infection within the first 24 hours. An early study used a
monoclonal antibody (RB6-8C5) specific for granulocyte receptor 1 (GR-1) to deplete
these cells, and demonstrated that mice depleted of neutrophils succumbed to an early,
lethal infection with 10-100 fold increased bacterial burdens in the liver (Conlan and
North, 1994). It has been suggested that neutrophils directly lyse Listeria infected
hepatocytes and actually engulf apoptotic hepatocytes (Rogers et al., 1996). Neutrophils
were also suggested to represent sources of pro-inflammatory cytokines such as IFN and
TNF which are required for the clearance of Listeria (Grivennikov et al., 2005; Yin and
Ferguson, 2009).
At the time of these conclusions, however, it was not appreciated that RB6-8C5
recognizes both Ly6G and Ly6C and accordingly depletes multiple types of cells
(Nagendra and Schlueter, 2004). Ly6G expression is restricted to neutrophils, whereas
Ly6C is expressed by neutrophils, inflammatory monocytes, and subsets of CD8+ T cells
(Fleming et al., 1993). Recent studies demonstrated that selective depletion of neutrophils
by the 1A8 anti-Ly6G mAb resulted in 10-1000 fold increased infection in livers and
with a higher dose of Listeria, increased bacterial burdens in the spleens were also
observed (Carr et al., 2011). In contrast, Shi et al. failed to see significant difference in
bacterial burdens after 1A8 treatment (Shi et al., 2011). This may be due to the same day
treatment of mAb with Listeria infection which causes the delayed deletion of neutrophils.
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Although neutrophils are one of the first cells to respond to Listeria infection, the
obsolete concept of the neutrophils as terminally differentiated, short-lived, and not
transcriptionally active cells has hampered researches on non-phagocytic roles of
neutrophils. Most investigations into the functions of IFN in innate immunity have also
overlooked the significance of IFN on the functions of neutrophils (Ellis and Beaman,
2004). However, in vitro treatment of neutrophils from peripheral blood with IFN elicits
a variety of responses such as oxidative burst, cytokine and chemokine production,
antigen presentation, phagocytosis, cytocidal effects, and chemotaxis. Thus, nontraditional roles of neutrophils which respond to cytokine stimuli such as IFN via gene
expression and regulation may be critical for Listeria resistance.

Summary of current findings
In this study, I hypothesized that IFN might act on the CD8+ DC subset to
initiate pathways leading to Listeria resistance. To investigate this issue, I generated mice
with a floxed Ifngr1 gene (Ifngr1f/f mice) on a pure C57BL/6 genetic background and
then bred them to either Vav-icre or Itgax-cre mice (that were backcrossed to >99%
C57BL/6 using speed congenics approaches) to impart IFN unresponsiveness either
broadly in hematopoietic lineage cells or specifically in the CD8+/CD103+ DC subset,
respectively (de Boer et al., 2003; Stranges et al., 2007). Using Itgax-cre+Ifngr1f/f mice, it
was shown that IFN derived from TNF-stimulated NK/NKT cells initiates the antiListeria response by triggering optimal IL-12 production by CD8+ DCs. I also identified
the importance of IFN responsiveness in neutrophils for control of Listeria infection
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using LysM-cre+Ifngr1f/f mice. Adoptive transfer of WT neutrophils, not Ifngr1-/neutrophils can rescue LysM-cre+Ifngr1f/f mice which lack IFN responsiveness in
neutrophils and a subset of macrophages.
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CHAPTER 2
Experimental procedures

Generation of the Ifngr1f/f mice
Ifngr1f/f mice were generated by placing two loxP sites around the third and
fourth exons that encode the extracellular domain of IFNGR1. A targeting vector,
TNLOX1-3 (Radtke et al., 1999), was used to generate the Ifngr1 conditional targeting
construct. A 1.3 kb fragment containing a part of the second intron, a 3.1 kb fragment
containing the third and fourth exons, and a 4.4 kb fragment with an exogenous BamHI
site containing the fifth and sixth exons of the murine Ifngr1 were cloned into the Not I,
Asc I, and PmeI sites respectively, of the targeting vector.
The Ifngr1 targeting construct was linearized by SalI (NEB) digestion and
electroporated into the B6/Blu embryonic stem cell line (Graubert et al., 1998). ES cells
were subjected to 600 g/ml of G-418 selection and single colonies were analyzed for
homologous recombination by PCR using a 5' external primer (f3: 5'ccagtgtttgcctttggatctg-3', IDT) and a Neo primer (r3: 5'-gttggctacccgtgatattgctg-3', IDT)
(Figure 1A). PCR positive clones were verified by Southern blot analysis using BamHI
restriction digest with 5' and 3' external probe (Figure 1A and Figure S2A). One ES clone
with the complete integration of the 3' region was further verified by PCR using each
loxP specific primer set (f1: 5'-aaacagtaaacccagggctttgtac-3'; r1: 5'cagcctctgaaattcaaatggc-3'; f2: 5'-gtgacgggagcacctgttac-3'; r2: 5'-gtaagtgcattcatctggccag-3',
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IDT). Southern blot analysis using Neo probe demonstrated a single integration of the
targeting vector into the endogenous Ifngr1 locus (Figure1A and data not shown).
The targeted ES clone was expanded and transiently transfected with pTurbo-Cre
(ES cell core, Washington University) for removal of Neo resistance gene from the
targeted allele of Ifngr1. Neo-sensitive clones were selectively picked and screened using
5' primers (5'-aaacagtaaacccagggctttgtac-3', IDT) and two 3’ primers (5'cagcctctgaaattcaaatggc-3', 5'-cgtggcactgtagatgtactgtcag-3', IDT) and were confirmed by
Southern blot analyses using the 5' probe. Neo-deleted subclones were injected into B6 8
cell embryo using the laser-assisted microinjection technique (Poueymirou et al., 2007).

Mice
B6 (C57BL/6NTac) mice were obtained from Taconic. Itgax-cre (007567;
C57BL/6J-Tg(Itgax-cre,-EGFP)4097Ach/J) mice (Stranges et al., 2007) and Vav-icre
(008610; B6.Cg-Tg(Vav1-cre)A2Kio/J) mice (de Boer et al., 2003) were obtained from
the Jackson Laboratory. To ensure pure B6 background, both Itgax-cre and Vav-icre mice
were backcrossed onto the C57BL/6 background by speed congenic analysis (>99%
purity, Rheumatic Diseases Core Center, Washington University) and then crossed to
Ifngr1f/f mice. Mice were maintained in a specific pathogen-free facility in accordance
with American Association for Laboratory Animal Science guidelines, and all protocols
involving laboratory animals were approved by the Washington University Animal
Studies Committee (School of Medicine, Washington University in St. Louis).
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Infection
Listeria monocytogenes (stain: EGD) from frozen glycerol stocks at -80℃ was
diluted into pyrogen-free saline. Mice were typically infected with a 105 dose of Listeria
i.p. for CFU measurement and with a 106 dose of Listeria i.v. for intracellular cytokine
staining. To measure bacterial burden, spleens and livers were harvested, homogenized in
PBS containing 0.05% Triton X-100, and plated onto brain heart infusion media.
Bacterial CFUs were determined after overnight incubation at 37℃. In some experiments,
small portions of spleens and livers were fixed in 10% formalin, embedded in paraffin,
and stained with hematoxylin and eosin (H&E).

Antibody treatment
For in vivo depletion of NK/NKT cells, Ifngr1f/f mice were treated with 200g
anti-NK1.1 mAb (PK136, Biolegend) i.p. on days -2 and 0 (relative to Listeria infection).
Memory phenotype CD8+ T cell depletion was achieved by injecting Ifngr1f/f mice i.p.
with 200g anti-CXCR3 mAb (CXCR3-173) on days -3 and 0. For IL-18 neutralization,
500g of anti-IL-18 mAb (SK113AE-4)(Lochner et al., 2002) was injected i.p. on day -1.
For IL-1//R neutralization, Ifngr1f/f mice were injected i.p. with 250g each of antiIL1 mAb (ALF-16)(Fuhlbrigge et al., 1988), anti-IL-1 mAb (B122)(Hogquist et al.,
1991), and anti-IL-1R mAb (JAMA-147)(Rogers et al., 1992) on day -1. Dual TNFR1
and TNFR2 blockade was achieved by i.p. injection of a mixture containing 250g each
of TNFR1 mAb (55R-170)(Sheehan et al., 1995) and TNFR2 mAb (TR75-54)(Sheehan
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et al., 1995) on day -1. For IFN neutralization, 250g of IFN-specific H22 mAb
(Schreiber et al., 1985) was injected i.p. on day -1.

Flow cytometry
The following monoclonal antibodies were purchased from Biolegend as lineage
markers: PerCP/Cy5.5 anti-CD3 (145-2C11), PE or APC anti-NK1.1 (PK136), FITC or
PE/Cy7 anti-CD4 (GK1.5), PerCP/Cy5.5 or APC/Cy7 anti-CD8 (53-6.7), FITC or PE
anti-CD45R/B220 (RA3-6B2), APC anti-CD317/PDCA-1 (927), FITC or PerCP/Cy5.5
anti-F4/80 (BM8), PerCP/Cy5.5 or PE/Cy7 anti-CD11b (M1/70), PE anti-CD115
(AFS98), APC/Cy7 anti-Ly6G&C/Gr-1 (RB6-8C3), APC/Cy7 anti-Ly6C (HK1.4),
PerCP/Cy5.5 anti-Ly6G (1A8), FITC or APC/Cy7 anti-CD11c (N418), PerCp/Cy5.5
anti-CD103 (2E7), APC anti-CD183/CXCR3 (CXCR3-173), FITC anti-CD62L (MEL14), PE anti-CD44 (IM7), PE anti-CD31 (MEC13.3). PE anti-CD122 (TM-1) and PE
anti-Siglec-F (E50-2440) were purchased from BD Biosciences. APC anti-Dec205
(205yekta) was purchased from eBioscience.
Single cell suspension from various tissues was prepared as following. Spleens
and thymuses were dispersed into single cells by homogenizing between the frosted ends
of the slides. Red blood cells were then lysed using red blood cell (RBC) lysing buffer
(Sigma) prior to passing through an 80 m strainer. Livers were perfused with HBSS via
portal vein, and pressed through a stainless steel mesh. Cell suspension was centrifuged
at 50 x g for 30 sec to remove hepatocytes. Supernatant was overlaid onto histopague1083 (Sigma) and centrifuged at 600 x g for 25 min at 25℃. The visible interface was
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collected, washed, and passed through 80 m strainer. Blood was collected into PBS
containing 5mm EDTA and lysed using RBC lysing buffer (Sigma). To harvest
peritoneal cavity resident cells, peritoneal cavities were lavaged with 10 ml PBS.
For staining for IFNGR1, cells were blocked with Fc Block (BD Biosciences) in
FACS buffer (PBS/2% fetal calf serum/0.1% sodium azide) on ice for 15 min. Cells were
stained with indicated lineage markers and biotin anti-IFNGR1 (GR20, BD Biosciences)
on ice for 1 hour (Figure 1). Cells were washed and stained with PE or APC-SA
(Biolegend) on ice for 30 min. Dead cells were excluded by PO-PROTM-1 (Invitrogen)
counterstaining. For intracellular pSTAT1 staining, cells were stained with indicated
lineage markers on ice for 1 hr following Fc Block, and washed twice. After incubation
with 1,000 units/ml IFN at 37℃ for 15 min, cells were fixed in 2%
paraformaldehyde/PBS at 37℃ for 10 min and permeabilized with 90% methanol/PBS
on ice for 1 hr. Cells were subsequently stained with Alexa647 anti-pSTAT1 (4a, BD
Biosciences) at RT for 1 hr. For intracellular cytokine staining, cells were stained with
lineage markers without in vitro re-stimulation or incubation with intracellular transport
blockers. To label dead cells, Fixable Viability Dye eFluor® 450 (eBioscience) was used
prior to fixation and permeabilization procedures with BD Cytofix/CytopermTM (BD
biosciences). Cells were subsequently stained with PE anti-IL-12p40 (C15.6, Biolegend),
PE/Cy7 anti-IFN (XMG1.2, Biolegend), PE/Cy7 anti-TNF (MP6-XT22, Biolegend),
and goat anti-NOS2 (Santa Cruz) followed by PerCP/Cy5.5 donkey anti-goat IgG (Santa
Cruz).
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Immunohistochemistry
Alexa488 anti-B220 (RA3-6B2), biotin anti-CD3 (145-2C11), and biotin antiCD11b (M1/70) were purchased from BD Biosciences. Alexa555-SA, Alexa555 goat
anti-Rat IgG (H+L highly Cross-Adsorbed), and Alexa647 goat anti-rabbit IgG (H+L
highly Cross-Adsorbed) were purchased from Invitrogen. Listeria O antiserum Poly Type
1 & 4 was purchased from BD Diagnostics. Alexa647 anti-CD11c (N418) was purchased
from eBioscience. Biotin anti-Siglec-1(MOMA-1) was purchased from BMA
Biomedicals. Rat anti-MARCO was purchased from Serotec.
Fresh spleens were embedded in Tissue-Tec OCT (Fisher) and 7 m sections
were cut. Frozen sections were brought to RT and fixed in acetone at 4℃ for 5 min. All
slides were blocked with CAS Block (Invitrogen) and stained with indicated antibodies
diluted in CAS Block. Four-color epifluorescence microscopy was performed with an
Olympus BX51 microscope equipped with a SPOT RT CCD camera (Diagnostic
Instruments). Monochrome images were acquired through DAPI/FITC/TRITC/Cy5
fluorescence filters (Chroma), pseudo-colored with SPOT RT camera software, and
merged with Adobe Photoshop.

Cytometric bead array (CBA)
Serum levels of IL-6, TNF, IFN, and MCP-1 were accessed by using CBA
Mouse Inflammation Kit (BD Biosciences) according to the manufacturer's instructions.
CBA data was analyzed with CELLQuest™ software and the CBA analysis software
package (BD Biosciences).
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Adoptive transfer of neutrophils
The femur and the tibia from both fore and hind legs were removed from mice,
and the tip of each extremity was cut off. Bone marrow was flushed out through the bone
using HBSS solution with a 23G syringe. After dispersing cell clumps using a 20G
syringe, the cell suspension was centrifuged (400g, 10 min, 4°C) and lysed using RBC
lysing buffer (Sigma). The cells were re-suspended in PBS, applied onto a two-layer
Percoll gradient of 80% and 62% Percoll (Amersham Pharmacia Biotech) in PBS (100%
Percoll contains nine parts Percoll and one part 10× PBS), and centrifuged (1000 g, 30
min, room temperature) with the centrifuge brake turned off. The fraction from the
62%/80% interface was harvested into PBS/0.5%FCS/2mM EDTA. This fraction was
further purified using Ly6G+ MACS purification kit (Miltenyi). The isolated cells were
analyzed by cytospin centrifugation followed by Wright-Giemsa staining (Merck). I
obtained 1 × 107 cells per mouse on average. The 3 × 106 neutrophils were adoptively
transferred into recipient mice intravenously as shown in Figure 35A.

Statistical analysis
The statistical analysis for differences in CFUs was performed by the MannWhitney test using Prism software (GraphPad Software). In the figures, each circle (or
triangles) represents an individual mouse, and the bar indicates the mean value of the
group. P values less than or equal to 0.05 were considered to be significant. Error bars
indicate standard error of the mean (SEM).
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Figure 1. Gating strategy and markers for delineation by flow cytometry
Cells from spleen were labeled with antibodies against lineage markers to detect the
following populations; CD3+CD4+CD8- T cell, CD3+CD4-CD8+ T cell, CD3NK1.1+ NK cell, CD3intNK1.1int NKT cell, B220+ B cell, CD11c+B220+PDCA-1+ pDC,
CD11bintF4/80+ macrophage, CD11b+Ly6C+LycG- monocyte, CD11b+Ly6CintLy6G+
neutrophil, CD11c+Dec205+CD8+ DC, CD11c+Dec205-CD4+CD11b+ DC, and CD4526

CD31+ endothelial cells. Cells from blood were labeled with antibodies against lineage
markers to detect the following populations; SSChiCD11b+GR1+ neutrophil,
SSChiSiglecF+ eosinophil, SSCloCD11b+CD115+ monocyte, SSCloCD3+CD4+CD8- T
cell, and SSCloCD3+CD4-CD8+ T cell. Cells from peritoneal cavity and liver were
labeled with antibodies against lineage markers to detect the following populations;
CD11c+NK1.1-CD103+Dec205+CD11b- DC, CD11c+NK1.1-CD103-Dec205-CD11b+ DC,
SSChiCD11b+Ly6G-F4/80+ Kupffer cell, and CD11c+NK1.1-B220+PDCA-1+ pDC.
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CHAPTER 3
Generation and characterization of Ifngr1f/f mice

We generated a conditional knockout allele of Ifngr1 in pure C57BL/6 strain ES
cells by placing two loxP sites surrounding the third and fourth exons that encode the
extracellular domain of IFNGR1. Deletion of this gene region induces a frame shift
mutation after exon 2, leaving only a minimal portion of IFNGR1 that would not bind
IFN (Figure 2). Southern blotting and PCR analyses for both loxP sites showed a correct
genotype of Ifngr1f/f (Figure 3A and B). Flow cytometric analysis of spleen, peripheral
blood, and thymus revealed that Ifngr1f/f mice were indistinguishable from normal
C57BL/6 mice on the basis of surface expression of IFNGR1 in hematopoietic cells
(Figure 4). Ifngr1f/f mice did not display any developmental abnormalities and showed no
problems reproducing.
In addition, Ifngr1-/- ES cell subclones in which the entire floxed region was
deleted were also obtained (Figure 5). The Ifngr1-/- allele was germline-transmitted
(Figure 6) giving rise to mice named Ifngr1WU-/- to distinguish them from Ifngr1-/- mice
previously generated on a 129/SvEv background by M. Aguet (Huang et al., 1993). Cells
from Ifngr1WU-/- mice neither expressed IFNGR1 nor displayed induction of
phosphorylated STAT1 (pSTAT1) after in vitro treatment with IFN (Figure 4 and 7).
However, cells from Ifngr1WU-/- mice were fully responsive to treatment with Type I
Interferons, specifically IFN5 and IFN.
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Figure 2. Targeting strategy for Ifngr1f/f mice
Only five (black vertical bar or box) of seven total exons are shown for simplicity. H1,
BamH1; Neo, neomycin resistance gene; TK, herpes simplex virus thymidine kinase
gene; open triangle, loxP site. Open gray box indicates 3' external southern probe to
verify 3' homologous recombination. Small arrowheads indicate pairs of primers used in
PCRs to confirm either 5' homologous recombination (f3/r3) or insertion of loxP sites
(f1/r1 and f2/r2).
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A

B

Figure 3. Germline transmission of Ifngr1f/f mice
(A) Confirmation of germline transmission by examining 3' side of targeted allele by
southern blotting. The wild type (+) allele gives the 7.1kb band and the targeted (f) allele
gives the 5.7kb band (Figure 2).
(B) Verification of correct insertion of both 34 bp-long loxP sites by PCR reactions. Both
reactions show 34 bp increased band size in the targeted allele compared to the wild type
allele.
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Figure 4. The normal expression of IFNGR1 in Ifngr1f/f mice
Expression of IFNGR1 was assessed by FACS analyzing spleen, peripheral blood
leukocytes (PBLs), and thymus from wild type, Ifngr1f/f, and Ifngr1WU-/- mice. Data are
representative of three separate experiments.
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Figure 5. Screening strategy for Ifngr1WU-/- mice
Only four (black vertical bar or box) of 7 total exons are shown for simplicity. Open gray
box indicates 5' external southern probe to verify both 5' homologous recombination and
cre-mediated deletion.
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Figure 6. Germline transmission of Ifngr1WU-/- mice
Confirmation of germline transmission by examining 5' side of targeted allele by
southern blotting. The wild type (+) allele gives the 10.4kb band and the knockout (-)
allele gives the 8.8kb band.
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Figure 7. Ifngr1WU-/- mice show no phosphorylation of STAT1 after in vitro IFN
stimulation
Measurement of phosphorylated STAT1 in Ifngr1WU-/- mice after in vitro IFN treatment.
Spleens were harvested from Ifngr1f/f, Ifngr1WU-/-, and Ifnar1-/-, and treated with IFN5
(10,000 U/ml), IFN (10,000 U/ml), and IFN (1,000 U/ml) for 10 minutes at 37℃ in
vitro. After stimulation, samples were fixed, permeablized, and stained with anti-phospho
STAT1 antibodies.
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CHAPTER 4
IFN responsiveness in hematopoietic cells is required to control Listeria infection

Vav-icre+Ifngr1f/f mice show the complete deletion of Ifngr1 in hematopoietic cells
To selectively delete Ifngr1 in hematopoietic cells, Ifngr1f/f mice were bred to
Vav-icre mice. Vav promoter elements induce ubiquitous expression of transgenes in all
hematopoietic cells (de Boer et al., 2003). CD8+ DCs, CD4+ DCs, macrophages, NK
cells, CD4+ T cells, CD8+ T cells, B cells, monocytes, and neutrophils from spleen of
Vav-icre+Ifngr1f/f mice neither expressed IFNGR1 on their surface nor phosphorylated
STAT1 after in vitro IFN stimulation (Figure 8 and 9). In contrast, CD31+CD45endothelial cells expressed IFNGR1, indicating that IFNGR1 expression in the nonhematopoietic compartment was not affected in Vav-icre+Ifngr1f/f mice.

Vav-icre+Ifngr1f/f mice succumb to Listeria infection
Next, I challenged Vav-icre+Ifngr1f/f mice with a 105 dose of Listeria i.p., and
found that both Vav-icre+Ifngr1f/f and Ifngr1WU-/- mice succumbed to infection by day 5,
whereas Ifngr1f/f mice resolved the infection (Figure 10A). Bacterial counts in spleens
from Vav-icre+Ifngr1f/f and Ifngr1WU-/- mice contained 10-fold more bacteria at day 1 and
100- to 1000-fold more Listeria at day 3 than control Ifngr1f/f mice (Figure 10B). Similar
results were also observed for liver colony counts. There were no significant differences
in bacterial burdens between Vav-icre+Ifngr1f/f and Ifngr1WU-/- mice. Increased bacterial
burdens in Vav-icre+Ifngr1f/f mice were evidenced by significantly increased numbers of
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Listeria foci in both the spleen and liver compared to Ifngr1f/f mice (Figure 11). Thus, our
Vav-icre+Ifngr1f/f mice functionally recapitulate the defect previously noted in Ifngr1-/BM chimeras (Yap and Sher, 1999) with respect to their requirement for IFN
responsiveness in the hematopoietic compartment.
It was measured serum cytokine/chemokine from blood in Ifngr1f/f and Vavicre+Ifngr1f/f mice at day 1 and 3 after infection using a cytometric bead array (Fig. 12).
Increased production of the major inflammatory cytokines such as IFN and IL-6 in the
early stage of infection was observed, which indicates increased bacterial burden in Vavicre+Ifngr1f/f mice in vivo coincides with increased cytokine production.
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Figure 8. Vav-icre+Ifngr1f/f has no IFNGR1 in hematopoietic compartment
IFNGR1 expression on splenocytes was measured using flow cytometry in Vavicre+Ifngr1f/f mice. The spleens and PBLs from Ifngr1f/f, Vav-icre+Ifngr1f/f, and Ifngr1WU-/were harvested and stained with either biotinylated anti-IFNGR1 mAb or Isotype Ab with
various lineage markers (Figure 1). Data are representative of two separate experiments
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Figure 9. Vav-icre+Ifngr1f/f has no phosphorylation of STAT1 in hematopoietic
compartment after in vitro IFN stimulation
Measurement of phosphorylated STAT1 in Vav-icre+Ifngr1f/f mice after in vitro
treatment. Both spleen and PBLs were harvested from Ifngr1f/f, Vav-icre+Ifngr1f/f, and
Ifngr1WU-/-. They were first stained with lineage markers and treated with IFN (1,000
U/ml) for 15 minutes at 37℃ in vitro. After stimulation, samples were fixed,
permeabilized, and stained with anti-pSTAT1 antibody. Data are representative of two
separate experiments.
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Figure 10. Vav-icre+Ifngr1f/f mice are susceptible to Listeria infection
(A) Survival of mice which were i.p. infected with 105 Listeria.
(B) Listeria CFUs per spleen and liver of Ifngr1f/f, Vav-icre+Ifngr1f/f, and Ifngr1WU-/- mice
which were i.p. infected with 105 Listeria. Each symbol represents an individual mouse.
Lines represent the mean Log10CFU. *, p ≤ 0.05; **, p ≤ 0.01; ***, p ≤ 0.001. Data are a
combination of at least two separate experiments.
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Figure 11. Vav-icre+Ifngr1f/f mice have increased histological lesions in spleen and
liver
H&E staining of infected spleens and livers from mice 3 days after infection (105 Listeria
i.p.). Right panels show magnified regions (dashed boxes in left panels). Scale bar for
spleen represents 200um in low-power images and 50um in high-power images; scale bar
for liver represents 100um in low-power images and 50um in high-power images.
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Figure 12. Vav-icre+Ifngr1f/f mice show increased production of early proinflammatory cytokines, IFN and IL-6
Infected Ifngr1f/f and Vav-icre+Ifngr1f/f were bled at indicated time points after infection,
and serum was analyzed for IFN and IL-6 concentration using cytometric bead array.
Data represent averages of serum concentration of cytokines from at least two separated
experiments (n ≥ 4 at each time point).
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CHAPTER 5
IFN responsiveness in CD8+/CD103+ dendritic cells is required for optimal
control of Listeria infection

Itgax-cre+Ifngr1f/f mice show selective IFN unresponsiveness in CD8+/CD103+
dendritic cells
To explore whether IFN responsiveness in DCs affects Listeria susceptibility in
intact animals, Ifngr1f/f mice were bred with Itgax-cre mice to produce DC-specific
deletion of Ifngr1 (Stranges et al., 2007). A specific strain of Itgax-cre mice was selected
because they had been generated directly on a C57BL/6 background and because our
previous experience with these mice showed that they were efficient in directing deletion
of floxed genes in dendritic cells and in the CD8+/CD103+ DC compartment particularly
(Diamond et al., 2011). These Itgax-cre mice express cre recombinase under the control
of the mouse integrin alpha X (CD11c) promoter which directs bicistronic cre and EGFP
protein expression to DCs. Although expression of CD11c occurs in NK cells, monocytes,
macrophages, neutrophils, and some B cells in addition to DCs, Itgax-cre+Ifngr1f/f mice
showed significant reductions in IFNGR1 expression primarily in CD8+ DCs, with
partial reductions occurring in splenic CD4+ DCs and macrophages (Figure 13). The
extent of Ifngr1 deletion correlated well with the level of simultaneous EGFP expression
(Figure 19). Having substantially diminished IFNGR1 expression in CD8+ DCs, I
measured the level of pSTAT1 and CD40 in these cells as functional readouts after in
vitro IFN treatment. In Itgax-cre+Ifngr1f/f mice, CD8+ DCs showed significant
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inhibition of STAT1 phosphorylation and CD40 upregulation by IFN (Figure 14 and 15).
In contrast, CD4+ DCs, macrophages, and the other hematopoietic cells showed relatively
normal responses.
Splenic CD8+ DCs and peripheral CD103+ DCs are thought to be functionally
and developmentally related, as both subsets are efficient at cross-presentation of cellassociated antigens and Batf3-/- mice lack both CD8+ and peripheral CD103+ DCs,
whereas other cell lineages remain intact (Bedoui et al., 2009; Hildner et al., 2008). As
CD103+ DCs exist in all peripheral tissues, the deletion of Ifngr1 in peritoneal and
hepatic CD103+ DCs was analyzed (Ginhoux et al., 2009). It was not surprising to find
that CD103+ DCs in the peritoneal cavity and liver exhibited an almost complete deletion
of Ifngr1 in Itgax-cre+Ifngr1f/f mice, whereas myeloid CD11b+ DCs from these tissues did
not (Figure 16). No other cell populations in these mice were found to exhibit defect in
either IFNGR1 expression or IFN responsiveness. Thus the Itgax-cre+Ifngr1f/f mice
display a highly specific IFN unresponsiveness within the CD8+/CD103+ DC
compartment.

Itgax-cre+Ifngr1f/f mice show increased susceptibility to Listeria infection
Both Ifngr1f/f and Itgax-cre+Ifngr1f/f were next challenged with a sublethal
Listeria dose and found no difference in mortality between Ifngr1f/f and Itgaxcre+Ifngr1f/f mice (Figure 17A). However, Itgax-cre+Ifngr1f/f mice exhibited significantly
increased Listeria burdens in both the spleen and liver during first 7 days of the infection,
and showed a 10- to 100-fold increase in colony forming units (CFUs) over Ifngr1f/f mice
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at day 3 (Figure 17B). Increased bacterial colonization was more prominent in the liver
than the spleen in Itgax-cre+Ifngr1f/f mice, due to the fact that resolution of Listeria
infection in the spleen began after day 3, but did not occur in the liver until day 7.
Histologically, increased bacterial burdens in Itgax-cre+Ifngr1f/f mice were reflected in
significantly increased numbers and sizes of Listeria foci in both the spleen and liver
compared to Ifngr1f/f mice (Figure 18). Despite the defects in the initial control of Listeria
infection, Itgax-cre+Ifngr1f/f mice were still able to develop sterilizing immunity and
resolve Listeria infection by day 15 (Figure 17B).
Two sets of data revealed that the increased susceptibility to Listeria infection in
Itgax-cre+Ifngr1f/f mice was due solely to IFN unresponsiveness in the CD8+/CD103+
DCs. First, Listeria infection did not up-regulate expression of the transgenic cre-EGFP
bicistronic construct (derived from the Itgax-cre mice) in other cell types thus ruling out a
temporally delayed deletion of IFNGR1 in them. Specifically, strong expression of EGFP
was detected in CD8+ DCs, less in CD4+ DCs, and not at all in other cell types before or
after Listeria infection (Figure 19). Second, previous histological studies showed that
Listeria is initially trapped by marginal zone macrophages (MZM) and metallophilic
MZM (MMM) in the splenic marginal zone, where these cells have direct access to
bacteria entering the spleen from the circulation (Aichele et al., 2003; Aoshi et al., 2009).
Thus, deletion of IFNGR1 in these cells could potentially favor Listeria expansion during
the initial stages of infection. Because of technical difficulties in detecting MZM and
MMM by flow cytometry, tissue frozen sections were co-stained for MARCO1, MOMA1, and CD11c, then analyzed sections by fluorescence microscopy (Figure 20). Neither
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MARCO1+ MZM nor MOMA-1+ MMM showed CD11c expression with or without
Listeria infection, which ruled out alterations in IFN responsiveness. Thus, increased
susceptibility to Listeria infection in Itgax-cre+Ifngr1f/f was solely due to IFN
unresponsiveness in the CD8+/CD103+ DC population.

IFN unresponsiveness in CD8+ DCs affects neither the transport of Listeria nor
the formation of granulomatous lesions in PALS
CD8+ DCs are responsible for the transport of Listeria from the splenic
marginal zone to the periarteriolar lymphoid sheath (PALS) (Edelson et al., 2011;
Neuenhahn et al., 2006). They are also involved in the subsequent formation of an early
granulomatous lesion in the PALS that contains granulocytes, NK cells, and monocytes
(Kang et al., 2008). Thus, it was assessed whether a deficit in IFN responsiveness by
CD8+ DCs affects these events and results in increased susceptibility to Listeria
infection in Itgax-cre+Ifngr1f/f mice. To address this issue, I examined the location of
Listeria and the formation of granulomatous lesions by immunohistochemistry at 18
hours following Listeria infection (Figure 21). In both Ifngr1f/f and Itgax-cre+Ifngr1f/f
mice, CD11b+ myeloid cells were clustered in the PALS as delineated by CD3 (T cells)
and B220 (B cells) staining. I also found extensive growth of Listeria which co-localized
with CD11b+ myeloid cells in PALS. These results suggest that both the normal
migration of Listeria infected CD8+ DCs and the subsequent clustering of innate cells
occurred regardless of their ability to respond to IFN.
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Figure 13. Itgax-cre+Ifngr1f/f has no IFNGR1 in splenic CD8+ DCs
Flow cytometry analysis to show no IFNGR1 expression in splenic CD8+ DCs in Itgaxcre+Ifngr1f/f mice. Data are representative of four separate experiments. IFNGR1 levels in
the indicated cellular subsets in Itgax-cre+Ifngr1f/f mice compared with Ifngr1f/f mice
were summarized in bar graph (expressed as a percentage of the mean fluorescence
intensity)
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Figure 14. Itgax-cre+Ifngr1f/f has no phosphorylation of STAT1 in CD8+ DCs after
in vitro IFN stimulation
Measurement of phosphorylated STAT1 in splenic DCs in Itgax-cre+Ifngr1f/f mice after
in vitro IFN treatment (1,000 U/ml) for 15 minutes at 37℃. Data are representative of
two separate experiments.
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Figure 15. Itgax-cre+Ifngr1f/f has no up-regulation of CD40 in CD8+ DCs after in
vitro IFN stimulation
Up-regulation of CD40 in splenic DCs in Itgax-cre+Ifngr1f/f mice after in vitro IFN
treatment. Splenic CD11c+ cells were positively enriched by MACS purification from
Ifngr1f/f, Itgax-cre+Ifngr1f/f, and Ifngr1WU-/-. They were treated with IFN (500 U/ml) for
18 hours at 37℃ in vitro and stained with anti-CD40 antibodies and lineage markers.
Data are representative of two separate experiments.
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Figure 16. Itgax-cre+Ifngr1f/f has no IFNGR1 in peripheral CD103+ DCs
FACS analysis to confirm no IFNGR1 expression in peripheral CD103+ DCs in Itgaxcre+Ifngr1f/f mice. The peritoneal cavity and liver from Ifngr1f/f, Itgax-cre+Ifngr1f/f, and
Ifngr1WU-/- were harvested and stained with either biotinylated anti-IFNGR1 mAbs or
Isotype Ab with various lineage markers (Figure S5). Data are representative of two
separate experiments.
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Figure 17. Itgax-cre+Ifngr1f/f mice are susceptible to Listeria infection
(A) Survival of mice which were i.p. infected with 105 Listeria.
(B) Listeria CFUs per spleen and liver of Ifngr1f/f, Itgax-cre+Ifngr1f/f, and Ifngr1WU-/mice which were i.p. infected with 105 Listeria. Each symbol represents an individual
mouse. Lines represent the mean Log10CFU. *, p ≤ 0.05; **, p ≤ 0.01; ***, p ≤ 0.001.
Data are a combination of at least two separate experiments.
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Figure 18. Itgax-cre+Ifngr1f/f mice have increased histological lesions in spleen and
liver
H&E staining of infected spleens and livers from mice at 5 days after infection (105
Listeria i.p.). Right panels show magnified regions (dashed boxes in left panels). Scale
bar for spleen represents 200 m in low-power images and 50 m in high-power images;
scale bar for liver represents 100 m in low-power images and 50 m in high-power
images.

51

Figure 19. Bacterial infection itself induces no change in CD11c expression in Itgaxcre+Ifngr1f/f mice
Mice were i.p. infected with 105 Listeria. Spleens were harvested at 3 days after infection,
gated as in Figure 1, and analyzed for expression of EGFP from Ifngr1f/f and Itgaxcre+Ifngr1f/f. Expression of EGFP is expected to have equimolar expression with cre
recombinase because Itgax promoter directs bicistronic cre and EGFP protein expression.
A graph shows geometric mean

SEM.
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Figure 20. Marginal zone macrophages (MZM) and metallophilic MZM do not show
up-regulation of CD11c expression by Listeria infection
Both Ifngr1f/f and Itgax-cre+Ifngr1f/f mice were i.v. infected with 107 Listeria. After 18
hours of infection, spleen sections were harvested and stained with either MOMA-1 or
MARCO (green), CD11c (red), and DAPI (blue).
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Figure 21. Immunostaining of splenic Listeria infection
Both Ifngr1f/f and Itgax-cre+Ifngr1f/f mice were i.v. infected with 107 Listeria. After 18
hours of infection, spleen sections were harvested and stained with Listeria O (red), B220
(pink), CD3/CD11b (green), and DAPI (Blue). Lower panels show magnified regions
(dashed boxes in upper panels).
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CHAPTER 6
IFN from TNF activated NK/NKT cells is required to prime CD8+ DCs for
optimal IL-12 production

IFN responsiveness in CD8+/CD103+ dendritic cells is required for early cytokine
production
The serum amounts of cytokines and chemokine in Ifngr1f/f and Itgaxcre+Ifngr1f/f mice were measured to determine whether the crucial cytokines and
chemokine were being produced normally in Itgax-cre+Ifngr1f/f mice (Figure 22). In
Ifngr1f/f mice, serum IFN, IL-6, MCP-1, and TNF production began to increase after
18 hours of infection, reached a peak at 18-72 hours, and decreased after 3 days of
infection which nicely correlated with the changes of bacterial burden. In contrast, in
Itgax-cre+Ifngr1f/f mice these inflammatory cytokines and chemokine increased after day
3 of infection and remained at high amounts until day 10 of infection, which may reflect
the increased bacterial burden in the Itgax-cre+Ifngr1f/f mice compared to Ifngr1f/f mice.
Surprisingly, Itgax-cre+Ifngr1f/f mice showed significantly decreased production of
cytokines and chemokine at the early phase of infection, especially 18 hours,
demonstrating that early systemic production of inflammatory cytokines and chemokine
in Itgax-cre+Ifngr1f/f mice is substantially delayed relative to Ifngr1f/f mice. Therefore, I
focused on identifying the defects in CD8+/CD103+ DCs that resulted in a decrease in
cytokine responses during the early stages of Listeria infection.
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IFN-insensitive CD8+ DCs display defective IL-12 production
IL-12 is essential for resistance to sublethal doses of Listeria and for optimal
IFN production by NK cells (Brombacher et al., 1999; Tripp et al., 1994). Previously,
IL-12p35-/- mice showed increases in the number and size of granulomatous lesions even
at low doses of Listeria (≤ 1000 organisms). Moreover, CD8+ DCs and monocytes have
been implicated as major cellular sources of IL-12 in Listeria infection (Kapadia et al.,
2011; Mitchell et al., 2011; Zhan et al., 2010). I therefore decided to examine IL-12
production by individual DC subsets during the first 24 hours of infection and determine
what effects endogenously produced IFN has on IL-12 production by these cells. To
address these issues, ex vivo intracellular cytokine staining was used to quantify the
frequency of IL-12 positive cells in spleen at 6, 9, 12, 18, and 24 hours after Listeria
infection (Figure 23). To obtain synchronized bacterial infections and generate enough
cytokine-producing cells for ex vivo analysis, Ifngr1f/f and Itgax-cre+Ifngr1f/f mice were
i.v. infected with a high dose of 106 Listeria. it was confirmed that i.v. infection of
Listeria resulted in increased bacterial burdens in Itgax-cre+Ifngr1f/f mice, similar to
results obtained with i.p. infection, which indicates that the defects in Listeria clearance
in Itgax-cre+Ifngr1f/f did not depend on a specific infection route (Figure 24).
The percentage of splenic CD8+ DCs producing IL-12p40 in Ifngr1f/f mice was
increased to 4.2% at 9 hours, reaching a peak level of 9.4% at 12 hours and 5.9% at 18
hours (Figure 23A and B). In contrast, the proportion of IL-12p40 producing CD8+ DCs
from Itgax-cre+Ifngr1f/f mice was significantly less (64% reduction at 9 hours, 74%
reduction at 12 hours, and 89% reduction at 18 hours). IL-12 production by CD8+ DCs
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in Ifngr1WU-/- mice was also examined at 9 hours post-infection (Figure 25). Surprisingly,
IL-12p40 producing CD8+ DCs from Ifngr1WU-/- mice was completely absent. I interpret
finding as indicating that CD8+ DCs absolutely require IFN responsiveness for IL12p40 production, and incomplete reduction in IL-12p40+CD8+ DC is due to
incomplete deletion of Ifngr1 in Itgax-cre+Ifngr1f/f mice
IL-12p40 production by CD8+ DCs subsided 24 hours after infection.
However, at this time, approximately 10% of Ly6Chi monocytes stained positively for IL12p40 in both Ifngr1f/f and Itgax-cre+Ifngr1f/f mice (Figure 23A and C). Recently, Ly6Chi
inflammatory monocytes were shown to be recruited from the bone marrow to site of
Listeria infection and differentiated into TNF and iNOS producing dendritic cells
(TipDC) (Serbina and Pamer, 2006; Serbina et al., 2003). Thus, I further established the
relationship of IL-12p40+Ly6Chi monocytes and TNF+iNOS+Ly6Chi TipDCs (Figure
26). Approximately 30% of IL-12p40+Ly6Chi monocytes had a phenotype ascribed to
TipDCs—identified by their production of TNF and iNOS and 60% of TipDCs
produced IL-12p40 at this time. Therefore, CD11cintCD11b+Ly6ChiLy6G- monocytes
displayed a temporally delayed production of IL-12p40 compared to CD8+ DCs.

IFN insensitivity in CD8+ DCs leads to a reduction of IFN from NK/NKTs
NK and NKT cells were identified as the major sources of IFN production
during the first 24 hours of Listeria infection (Figure 27). IL-12 is known to be required
for early IFN production by NK cells (Tripp et al., 1993). Therefore the consequences of
IFN unresponsiveness in CD8+ DCs on the early induction of IFN was examined.
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The percentage of IFN+ NK/NKT cells in Itgax-cre+Ifngr1f/f mice was
significantly decreased compared to that in Ifngr1f/f mice at both 9 and 12 hours after
infection (NK cells: 68% reduction at 9 hours and 25% reduction at 12 hours; NKT cells:
58% reduction at 9 hours and 35% reduction at 12 hours) (Figures 27A-C). The reduced
percentage of IFN+ NK/NKT cells from Itgax-cre+Ifngr1f/f mice occurred concomitantly
with the decreased percentage of IL-12p40+CD8+ DCs (Figure 23). However, the levels
of IFN+ NK/NKT cells in Itgax-cre+Ifngr1f/f mice recovered to the those found in
Ifngr1f/f mice by 18 to 24 hours when Ly6Chi inflammatory monocytes produced the
second wave of IL-12p40. CD4+ DCs, plasmacytoid DCs, CD4+ T cells, B cells,
macrophages, and neutrophils were not a significant source of either IL-12 or IFN in the
first 24 hours of Listeria infection (Figure 28).

NK/NKT cells provide IFN to CD8+ DCs for optimal IL-12 production
Our data show direct effects of IFN on CD8+ DCs, and therefore I reasoned
that there may be an interacting cellular loop between NK cells and CD8+ DCs.
Specifically it was explored whether NK/NKT cells first produced IFN that primes
CD8+ DCs for the first wave of IL-12 production. To test this idea, NK/NKT cells was
depleted by treating Ifngr1f/f mice with NK1.1 mAb, and asked whether there was a
corresponding decrease in IL-12 production by CD8+ DCs (Figure 29A). To prevent the
possibility that increased bacterial burdens caused by NK/NKT depletion might directly
affect cytokine production, IL-12p40 at 9 hours after infection was measured. This was
the earliest time point at which IL-12p40 production by CD8+ DCs could be detected
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(Figure 23). It also preceded the exponential growth phase of Listeria (Carrero et al.,
2009). In mice treated with anti-NK1.1 mAb both NK and NKT cells were depleted, and
the percentage of IL-12p40+CD8+ DCs was 60% decreased (Figure 29B). These results
point to a crosstalk between NK/NKT cells and DCs, as IFN from NK/NKT cells is
responsible for initiating IL-12 production from CD8+ DCs, and DC-produced IL-12
then stimulates more IFN production from NK/NKT cells.
CD8+ T cells were also identified as a subsequent source of IFN production at
18 hours although the percentages of IFN+ CD8+ T cells were much smaller than those
of NK/NKT cells (Figure 27A and D). As memory phenotype (MP) CD8+ T cells were
shown to produce IFN without their cognate antigens after Listeria infection (Berg et al.,
2003), IFN+ CD8+ T cells resembled previously reported MP CD8+ T cells, as they were
CD44hiCXCR3+CD62Lhi (Figure 30). A recent study demonstrated that MP CD8+ T cells
secreted IFN two hours after S. Typhimurium infection, however I failed to detect IFN
production in MP CD8+ T cells until 18 hours after Listeria infection (Kupz et al., 2012).
It was possible that very early IFN production by MP CD8+ T cells occurred and was
below the detection limit of flow cytometry but might provide another source of IFN
that activated CD8+ DCs. To address this idea, MP CD8+ T cells were depleted using a
CXCR3 mAb developed in our lab (Uppaluri et al., 2008). Using our hamster CXCR3173 mAb, we previously showed that CXCR3 was expressed most highly in MP
CD8+CD44+ T cells, and in vivo treatment with anti-CXCR3 mAb selectively depleted
MP CD8+CD44+CD122+ T cells (Figure 31). Mice treated with CXCR3-173 mAb
exhibited no reduction in IL-12p40 production (Figure 29B) despite complete elimination
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of the MP CD8+ T cell population. Further, combined treatment with CXCR3-173 mAb
and anti-NK1.1 mAb showed no further inhibition of IL-12 production from that seen
with anti-NK1.1 mAb alone. These results indicate that memory phenotype CD8+ T cells
are not the source of the early IFN that primes CD8+ DCs for IL-12p40 production.

TNF initiates the reciprocal activation of NK/NKTs and CD8+ DCs to produce
IFN and IL-12
While the results presented thus far show that optimal early IL-12 production
from CD8+ DCs is a consequence of early IFN production by NK/NKT cells, they did
not identify the cytokine(s) responsible for the IFN that initiates the entire process. As
TNF, IL-18, and IL-1 are known to induce IFN from NK cells upon Listeria infection
(Humann and Lenz, 2010; Tripp et al., 1993; Tsuji et al., 2004), I analyzed IFN and IL12p40 production after treating Ifngr1f/f mice with neutralizing antibodies specific either
for these cytokines or their receptors and infecting with Listeria (Figure 32). It was found
that the reciprocal activation of NK/NKT cells and CD8+ DCs after Listeria infection
was TNF-dependent. To insure that both soluble and cell surface TNF were
neutralized, mAbs specific for each of the two TNF receptors (TNFR) were used. Dual
blockade of TNFR1 and TNFR2 caused a 54% and 79% decrease in IFN+ NK and NKT
cells, respectively, which was accompanied by a 75% reduction in IL-12p40+CD8+ DCs.
Direct neutralization of IFN using a IFN specific mAb achieved a comparable 78%
decrease in IL-12p40+CD8+ DCs (Figure 32A). In contrast, IL-18 neutralization had no
effect on IL-12p40 production, although IL-18 neutralizing mAb in combination with
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TNFR1 plus TNFR2 blocking mAbs down-regulated IFN+ NK cells 23% more than dual
TNFR-blockade alone (Figure 32B). A cocktail of neutralizing IL-1 IL-1 and
blocking IL-1R1 mAbs caused a 30% decrease in IL-12p40+CD8+ DCs without altering
the percentage of IFN+ NK/NKT cells (Figure 32A). Thus, the initial production of IFN
from NK/NKT cells early in Listeria infection that sets in motion a reciprocal activation
of NK/NKT cells and CD8+ DCs is a consequence of a process induced predominantly
by TNF with potential participation of other early arising pro-inflammatory cytokines.
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Figure 22. Itgax-cre+Ifngr1f/f mice show delayed production of early proinflammatory cytokines and chemokine
Infected Ifngr1f/f and Itgax-cre+Ifngr1f/f were bled at indicated time points after infection,
and serum was analyzed for IFN (A), MCP-1 (B), IL-6 (C), and TNF (D)
concentration using CBA. Data represent averages of serum concentration of
cytokines/chemokine through the course of infection from at least two separated
experiments (n ≥ 4 at each time point).
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Figure 23. The early production of IL-12p40 from CD8+ DCs is significantly
decreased in Itgax-cre+Ifngr1f/f mice
Itgax-cre+Ifngr1f/f and Ifngr1f/f mice were i.v. infected with 106 Listeria. Spleens were
harvested at 6, 9, 12, 18, and 24 hours after infection, and analyzed for the cellular source
of IL-12p40 by intracellular cytokine staining.
(A) Representative flow cytometry plots for IL-12p40 expression from cells gated on
CD11c+Dec205+CD8+ DCs and CD11b+Ly6C+Ly6G- monocytes. For each quadrant,
gating was based on cells from uninfected controls that were performed at every time
point (For simplicity, only the uninfected control at 9 hours after infection is shown).
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(B and C) Percentages of IL-12p40 positive CD8+ DCs, IL-12p40 positive Ly6C+
monocytes in the spleen during 24 hours of Listeria infection (n ≥ 4 at each time point). *,
p ≤ 0.05.
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Figure 24. Itgax-cre+Ifngr1f/f mice show increased bacterial burden after
intravenous infection
Listeria CFUs per spleen and liver of Ifngr1f/f and Itgax-cre+Ifngr1f/f mice at 3 days after
i.v. infection with 103 or 104 Listeria. Each symbol represents an individual mouse. Lines
represent the mean Log10CFU. *, p ≤ 0.05; **, p ≤ 0.01.
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Figure 25. The early production of IL-12p40 from CD8+ DCs is completely
abrogated in Ifngr1WU-/- mice
Itgax-cre+Ifngr1f/f and Ifngr1f/f mice were i.v. infected with 106 Listeria. Spleens were
harvested at 9 hours after infection and analyzed for the cellular source of IL-12p40 by
intracellular cytokine staining.
(A) Representative flow cytometry plots for IL-12p40 expression from cells gated on
CD11c+Dec205+CD8+ DCs and CD11c+Dec205-CD4+ DCs.
(B) Percentages of IL-12p40 positive CD8+ DCs in the spleen after 9 hours infection. **,
p ≤ 0.01.
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Figure 26. Listeria infection induces TipDCs to produce IL-12p40
At 24 hours after i.v. infection with 106 Listeria, Ifngr1f/f and Itgax-cre+Ifngr1f/f mice
were analyzed for TNF and iNOS expression on IL-12p40 producing monocytes.
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Figure 27. The early production of IFN from NK and NKT cells is significantly
decreased in Itgax-cre+Ifngr1f/f mice
Itgax-cre+Ifngr1f/f were i.v. infected with 106 Listeria. The cellular sources of IFN in
spleen were analyzed by intracellular cytokine staining at 6, 9, 12, 18, and 24 hours after
infection.
(A) Representative plots for IFN which were gated on CD3-NK1.1+ NKs, CD3intNKint
NKTs, and CD3+CD8+ T cells.
(B) Percentages of IFN positive NKs, NKTs, CD8+ T cells in the spleen during 24 hours
of infection (n ≥ 4 at each time point). *, p ≤ 0.05.
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Figure 28. Flow cytometry analysis for IL-12 and IFN through the course of
infection
Ifngr1f/f and Itgax-cre+Ifngr1f/f were i.v. infected with 106 Listeria. Spleens were
harvested at 6, 9, 12, 18, and 24 hours after infection, gated as in Figure 1, and analyzed
for the cellular source of IL-12 and IFN by intracellular cytokine staining. Data are
representative FACS plots. Each quadrant gating was based on no infection controls that
were done at every time point (only no infection control at 6 hours after infection is
shown for simplicity).
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Figure 29. Depletion of NK/NKT cells significantly reduces IL-12p40 production
from CD8+ DCs
Ifngr1f/f and Itgax-cre+Ifngr1f/f mice treated with indicated mAbs were i.v. infected with
106 Listeria. Spleens were harvested at 9 hours after infection, and analyzed for IL-12p40
production from CD8+ DCs by intracellular cytokine staining.
(A) Representative FACS plots for the depletion of NK/NKT cells by anti-NK1.1 mAb,
for the depletion of MP CD8+ T cells by anti-CXCR3 mAb, and for IL-12p40 production
from CD8+ DCs after depleting mAb treatments.
(B) Summary of percentages of IL-12p40 positive CD8+ DCs after depleting mAb
treatments. **, p ≤ 0.01.

70

Figure 30. Listeria infection induces memory phenotype CD8+ T cells to produce
IFN
At 24 hours after i.v. infection with 106 Listeria, Ifngr1f/f and Itgax-cre+Ifngr1f/f mice
were analyzed for CD44, CXCR3, and CD62L on IFN producing CD8+ T cells by flow
cytometry.
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Figure 31. Selective depletion of memory phenotype CD8+ T cells by anti-CXCR3
mAb
(A) The summarized CXCR3 expression in the indicated cellular subsets to show the
strongest expression of CXCR3 in memory phenotype (MP) CD8+ T cells of B6 WT
mice.
(B) B6 WT mice were i.p. injected with 40, 200, and 1000 g of anti-CXCR3, and 3 days
later the frequency of MP CD8+ T, MP CD4+ T, NK, and NKT cells were analyzed by
flow cytometry.
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Figure 32. Neutralization of TNF reduces both IL-12 production from CD8+ DCs
and IFN production from NK/NKT cells
Ifngr1f/f and Itgax-cre+Ifngr1f/f mice treated with indicated mAbs were i.v. infected with
106 Listeria. Spleens were harvested at 9 hours after infection, and analyzed for the
cellular source of IL-12p40 and IFN by intracellular cytokine staining. Percentages of
IL-12p40 positive CD8+ DCs (A), IFN positive NKs (B), and IFN positive NKTs (C)
in the spleen were plotted as bar graphs. *, p ≤ 0.05; **, p ≤ 0.01; ***, p ≤ 0.001.
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CHAPTER 7
IFN responsiveness in neutrophils is required to control Listeria infection

LysM-cre+Ifngr1f/f mice show a relatively selective IFN unresponsiveness in
neutrophils
Next,

Ifngr1f/f

mice

were

bred

with

LysM-cre

mice

to

obtain

macrophage/neutrophil specific Ifngr1 deletion. As expected, both resident peritoneal
macrophages and neutrophils are sensitive to cre-mediated deletion under the control of
LysozymeM promoter (Figure 33A). However, it is noteworthy that IFNGR1 expression
on red pulp macrophages in the spleen and kupffer cells in liver was not affected. Having
substantially diminished IFNGR1 expression in resident peritoneal macrophages and
neutrophils, the level of pSTAT1 in these cells was measured as functional readouts after
in vitro IFN treatment. In LysM-cre+Ifngr1f/f mice, both resident peritoneal macrophages
and neutrophils showed significant inhibition of STAT1 phosphorylation by IFN (Figure
33B).

LysM-cre+Ifngr1f/f mice succumb to Listeria infection
LysM-cre+Ifngr1f/f mice were infected to test their susceptibility to Listeria. After
challenging with a sub-lethal dose of Listeria (1 x 105), half of the LysM-cre+Ifngr1f/f
mice died within 2 weeks after infection while most of Ifngr1f/f mice survived (Figure
34A). When LysM-cre+Ifngr1f/f mice were challenged and bacterial titers in spleens and
livers from the survivors were monitored, LysM-cre+Ifngr1f/f mice exhibited significantly
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increased Listeria burdens compared to infected control mice (Figure 34B). Increased
bacterial colonization was more prominent in the liver than the spleen in LysMcre+Ifngr1f/f mice. Increased Listeria burdens in liver were observed at the early phase of
infection, with a 6-fold increase in CFUs over Ifngr1f/f mice at day 1, and were
heightened up to 17,000-fold increase at day 7. In contrast, there was no difference in
early splenic bacterial titers at day1 and 3.
We previously demonstrated that IFNGR1 expression on peritoneal macrophages
is essential for host survival during LM infection (Dighe et al., 1995). However, it
remains unclear whether the increased susceptibility of LysM-cre+Ifngr1f/f mice is due to
IFN insensitivity in neutrophils. Recently, it has been shown that neutrophils are
specifically required for optimal clearance of Listeria from liver using the Ly6G mAb
that selectively depletes Ly6G+ neutrophils (Carr et al., 2011). In these neutrophildepleted mice, bacterial clearance in spleen was less dependent on neutrophils than in
liver. This observation is consistent with my findings that LysM-cre+Ifngr1f/f mice had a
more prominent bacterial infection in liver than in spleen. To explore whether neutrophils
require IFN sensitivity in more detail, I adoptively transferred WT or Ifngr1-/neutrophils into LysM-cre+Ifngr1f/f mice and asked whether it could rescue the Listeria
sensitivity of these mice (Figure 35A and B). Surprisingly, WT neutrophils completely
restored the resistance of LysM-cre+Ifngr1f/f mice to Listeria infection in spleen and liver,
whereas Ifngr1-/- neutrophils did not (Figure 35C).
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Figure 33. LysM-cre+Ifngr1f/f has no functional IFNGR1 in neutrophils and
peritoneal macrophages.
(A) IFNGR1 expression on various hematopoietic cells was measured using flow
cytometry in LysM-cre+Ifngr1f/f mice. The spleen/PBLs/liver/peritoneal cavity from
Ifngr1f/f, LysM-cre+Ifngr1f/f, and Ifngr1WU-/- were harvested and stained with either
biotinylated anti-IFNGR1 mAb or Isotype Ab with various lineage markers (Figure 1).
IFNGR1 levels in the indicated cellular subsets in LysM-cre+Ifngr1f/f mice compared with
Ifngr1f/f mice were summarized in bar graph. (B) Measurement of phosphorylated
STAT1 in splenocytes from LysM-cre+Ifngr1f/f mice after in vitro IFN treatment (1,000
U/ml) for 15 minutes at 37℃.
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Figure 34. LysM-cre+Ifngr1f/f mice are susceptible to Listeria infection
(A) Survival of mice which were i.p. infected with 105 Listeria. (B) Listeria CFUs per
spleen and liver of Ifngr1f/f, LysM-cre+fngr1f/f, and Ifngr1WU-/- mice which were i.p.
infected with 105 Listeria. Each symbol represents an individual mouse. Lines represent
the mean Log10CFU. *, p ≤ 0.05; **, p ≤ 0.01; ***, p ≤ 0.001.
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Figure 35. Adoptive transfer of WT neutrophils rescues LysM-cre+Ifngr1f/f mice
from Listeria infection
(A and B) Neutrophils were isolated from WT and Ifngr1-/- bone marrows and were
adoptively transferred into Listeria infected LysM-cre+fngr1f/f mice at day 0 and 2 as
shown. (C) Listeria CFUs per spleen, liver, and peritoneal cavity of Ifngr1f/f, LysMcre+fngr1f/f, WT neutrophils-transferred LysM-cre+fngr1f/f, and KO neutrophilstransferred LysM-cre+fngr1f/f mice. Each symbol represents an individual mouse. Lines
represent the mean Log10CFU. *, p ≤ 0.05; **, p ≤ 0.01; ***, p ≤ 0.001.
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CHAPTER 8
Discussion and future directions

The role of IFN in augmenting the production of IL-12 by myeloid cells was
initially suggested by in vitro studies showing that pretreatment of macrophages with
IFN before addition of heat-killed Listeria (HKLM) greatly enhanced their capacity to
produce IL-12 (Dighe et al., 1995). This conclusion was also supported by other in vitro
studies that used the macrophage-like RAW 264.7 cell line to show that IFN enhanced
transcription of the genes encoding both IL-12p40 and IL-12p35 (Trinchieri, 2003). In
contrast, the initial production of IL-12 by CD8+ DC was found to be independent of
IFN at least in response to Toxoplasma gondii (Scharton-Kersten et al., 1996). However,
despite the significant amount of data pointing to a critical interaction between IFN and
IL-12 during the development of immune responses to microbial pathogens, the cells
responsible for initiating this interaction and the temporal sequence of the events by
which they occur in vivo remained obscure.
In the current study, we generated novel mice displaying conditional deletion of
the Ifngr1 gene and used them to clarify the roles and cellular targets of IFN and IL-12
during initiation of protective immune responses against Listeria monocytogenes. Ifngr1f/f
mice bred to Vav-icre mice were first analyzed to validate the effectiveness of our
targeting and observed selective deletion of Ifngr1 in hematopoietic cells. The resulting
mice were highly susceptible to Listeria infection, a result that confirmed an earlier report
that IFN responsiveness in hematopoietic cells was required to resolve systemic Listeria
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infection (Yap and Sher, 1999). We then generated mice that lacked Ifngr1 selectively in
CD8+/CD103+ DCs by crossing our Ifngr1f/f mice to a specific line of Itgax-cre mice
that preferentially drives cre expression in DCs. Using these mice I show that IFN acts
on CD8+ DCs to initiate the early production of IL-12 responsible for enhancing
production of more IFN thereby establishing a pathway that controls the earliest stages
of Listeria infection. Furthermore, Ifngr1f/f mice bred to LysM-cre which lacks IFN
responsiveness in neutrophils and a subset of macrophages allowed us to identify
neutrophils as one of the critical IFN-dependent effectors. Thus, our data identify
CD8+ DCs as both critical responders to IFN that is initially produced upon infection
as well as the primary source of early IL-12 that is required to drive optimal IFN
dependent anti-bacterial immune responses such as neutrophil activation durin Listeria
infection (Figure 36).
Our study shows that IL-12 production from CD8+ DCs is transient and ceases
24 hours post-infection. The mechanism(s) underlying the transient nature of this initial
IL-12 production is currently unknown. It is possible that infection of CD8+ DCs results
in their rapid elimination. Disappearance of CD8+ DCs has been reported by others to
occur at approximately 18 hours post-infection (Edelson et al., 2011). However, it is also
possible that IL-12 production may be actively inhibited in these cells by IL-10 that may
arise as a consequence of the infection. IL-10 is known to be a powerful inhibitor of IL12 produced by dendritic cells (Huang et al., 2001). More work is needed to define the
events that limit the initiation phase of the process.

80

Nevertheless, even though mice with IFN unresponsive CD8+ DC show
significant deficits in their capacity to produce IL-12 and display a highly compromised
capacity to control the early stages of Listeria infection, they eventually control the
infection. I show that Ly6Chi inflammatory monocytes produce IL-12 that provides a
mechanism to control the infection. The identification of inflammatory monocytes as an
important source of IL-12 agrees with results of earlier studies (Kapadia et al., 2011; Tam
and Wick, 2006; Zhan et al., 2010). Importantly, even though CD8+ DCs, inflammatory
monocytes, and even CD11b+ DCs have been identified as major sources of IL-12, the
temporal aspects of their functions have, until now, not been investigated. Herein, it was
shown that IL-12 production from CD8+ DCs occurs first and requires the priming
actions of IFN on these cells. This step is then followed by a shift of IL-12 production
by inflammatory monocytes. As shown by others (Tam and Wick, 2006), one third of IL12-producing Ly6Chi inflammatory monocytes additionally produced TNF and iNOS,
thus identifying them as TipDCs (Serbina et al., 2003). IFN is required for the activation
and maturation of TipDCs (Kang et al., 2008) and furthermore NK cell-produced IFN
promotes the local differentiation of inflammatory monocytes into CD11c+MHCII+ DCs
which serves as the major source of IL-12 during T. gondii infection (Goldszmid et al.,
2012). During Listeria infection, Ly6Chi monocytes may also need to be primed by IFN
in order to optimally produce the second wave of IL-12. This possibility will be
examined in future experiments once we breed IFN insensitivity selectively into these
cells.
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CD8+ DCs play an obligate role in transporting Listeria into the PALS and
thus are critical for establishing a productive infection (Edelson et al., 2011; Neuenhahn
et al., 2006). Yet these same cells are also thought to be crucial for recruiting and
activating innate cells in the foci of bacterial infection (Kang et al., 2008). It is therefore
significant that at 12 hours, these foci contained CD8+ DCs, IL-12, IFN+ NK cells,
neutrophils, and Listeria - essentially all the components needed to initiate the antiListeria response. While the selective abrogation of IFN responsiveness in CD8+ DCs
did not impede any spatial regulation of innate cell clustering and Listeria proliferation, I
demonstrate that IFN responsiveness in CD8+ DCs is important for reciprocal
activation of CD8+ DCs and NK/NKT cells. Although a kinetic analysis was conducted
to understand the causal link between IFN production by NK/NKT cells and IL-12
production by CD8+ DCs via flow cytometry, we are unable to determine which
cytokine precedes the other. Similarly, in situ histologic approaches by Kang et al.
revealed that IFN and IL-12 production coincided with each other at 12 hours post
infection (Kang et al., 2008). When the levels of TNF, IL-6, IFN, and IL-12 were
monitored during Listeria infection, no obvious lag between onset of IL-12 and IFN
could be detected in vivo, although production of TNF was shown to precede the other
cytokines (Liu and Kurlander, 1995; Nakane et al., 1992).
We showed previously that TNF directly stimulates the release of IFN from
NK cells (Tripp et al., 1993; Wherry et al., 1991), and it was demonstrated here that
blockade of TNF signaling inhibits the reciprocal activation of NK/NKT and CD8+
DCs. Mice lacking both TNF receptors (TNFR1 and TNFR2) were also shown to be
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deficient in IL-12 production, suggesting that TNF plays a role in the eventual induction
of IL-12 in response to Listeria infection (Zhan and Cheers, 1998). Thus, our findings
suggest a model wherein TNFpotentiates the first wave of IFN from NK/NKT cells,
which then induces CD8+ DCs to produce IL-12 that stimulates NK/NKT cells to
produce more IFN. Of note, our studies do not exclude a possible role of direct cellular
interactions between NK/NKT cells and CD8+ DCs. Functional interactions between
NK cells and DCs are dependent upon both cell contact as well as cytokine production
(Gerosa et al., 2002; Piccioli et al., 2002). Interestingly, Xu et al. reported that DCs
stimulate IFN production from NK cells via triggering of TNFR2 on NK cells by
transmembrane TNF on DCs, instead of soluble TNF (Xu et al., 2007). Our results
support this concept because whereas we could inhibit early IFN and IL-12 production
by mAbs that neutralize TNF receptors, we could not block them with our TN3-19.12
mAb (Sheehan et al., 1989) that potently neutralizes the soluble form of TNF but not
membrane-bound TNF (data not shown). Thus, our data suggest that reciprocal
activation between NK/NKT and CD8+ DC is likely to occur in infection foci where
DCs facilitate the clustering of NK cells via direct contact and cytokine secretion and are
therefore consistent with the conclusion of a previous report by others (Kang et al., 2008).
The current study was possible because of the availability of the novel mice
generated in this thesis that were engineered to display IFN unresponsiveness in specific
tissues. Although mice with systemic IFNGR1 deficiency have been available for almost
20 years (Huang et al., 1993), the mice generated for this study are the first, to our
knowledge, to display tissue specific deficiency of the Ifngr1 gene. Recently, Kernbauer
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et al. reported the use of mice with conditional deletion of the Stat1 gene in DCs to study
anti-Listeria responses (Kernbauer et al., 2012). Although STAT1 indeed plays a critical
role in IFNR signaling, it is also required for IFNR signaling. In Listeriosis, IFN is
host protective while Type I IFNs are detrimental to the host (Carrero et al., 2006). Thus,
the use of mice that lack the ability to respond to both classes of IFNs makes the
interpretation of their results difficult.
In summary, the results of this thesis project indicate that IFN from NK/NKT
cells directly potentiates IL-12 production from CD8+ DCs. Considering that CD8+
DCs transport Listeria and recruit innate cells such as NK/NKT cells into infection foci,
the induction of IL-12 production by IFN appears to be both time- and location-specific.
Thus, NK/NKT production of IFN and subsequent IL-12 production by CD8+ DCs are
critical initiators of the innate response to Listeria which lead to IFN-mediated
activation of effect cells such as macrophages and neutrophils.

Future directions
Our identification of CD8+ DCs and neutrophils as important targets of IFN
provides the basis for future experiments using Ifngr1f/f mice to further dissect the role of
IFN signaling in different cell types during Listeria infection. Currently, Ifngr1f/f mice
have been bred with CD4-cre, NKp46-cre, Foxp3-GFP-cre, and VE-cadherin-creERT2
(Table 1).These mice will be also useful to study abilities to resist infection by other
microbial pathogens such as Leishmania major, and several mycobacteria species,
including M. Bovis and M. avium which require IFN responsiveness to be resolved
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(Bach et al., 1997).
For example, IFN signaling in T cells skews the differentiation of naïve CD4 T
cells into Th1 cells (Dighe et al., 1995; Macatonia et al., 1993). After breeding Ifngr1f/f
mice with CD4-cre mice which selectively delete Ifngr1 in T cells (Figure 37), we will
explore the possibility that lack of IFN signaling in T cells skews the in vivo
differentiation of naïve CD4+ T cells away from Th1 cells towards the other CD4+ T cell
subsets i.e., Th2, Treg, or Th17 by a variety of immunological stimuli. Th2 and Treg cells
are thought to deteriorate anti-bacterial and tumor responses by inhibiting cellular
immunity. In contrast, Th17 cells are uniquely primed to mediate surveillance and early
defense during infections by bacterial, mycobacterial, and fungal pathogen although Th17
cells have become notorious for their involvement in a range of autoimmune diseases
(Stockinger and Veldhoen, 2007). In addition to affecting the induction of primary T cell
response, IFN is also relevant to the contraction phase of T cell response (Badovinac et
al., 2000). This study demonstrated that CD8+ T cells failed to contract in IFNγ-deficient
mice after infection with an attenuated (actA-deficient) strain of Listeria. Furthermore,
the absence of IL-12 receptor on antigen-specific T cells not only reduced the contraction,
but also increased the generation of memory T cells against Listeria (Pearce and Shen,
2007). Thus, the reciprocal activation of CD8+ DCs and NK/NKT cells inducing initial
production of both IFN and IL-12 is likely to be crucial for regulating primary and
memory T cell responses against bacterial infection.
Furthermore, the fact that these mice were generated on a pure C57BL/6 genetic
background will make them widely useful for many different types of studies inducing
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those where homogenous genetic backgrounds are a critical consideration such as tumor
transplantation studies. We observed that IFN signaling is required for rejection of
transplantable sarcomas (Dighe et al., 1994) and for prevention of primary tumor
outgrowth (Kaplan et al., 1998). Previously we focused our efforts on defining the effects
of IFNon the developing tumor itself and showed that IFNfunctions, at least in part, to
enhance tumor cell immunogenicity by up-regulating its MHC class I antigen processing
and presentation pathway (Shankaran et al., 2001; Strehl et al., 2005). However, our
initial observations also pointed to an important role for IFN at the level of the host in
controlling tumor outgrowth. Others also noted that host cell responsiveness to IFN is
important for development of protective anti-tumor responses (Fallarino and Gajewski,
1999; Qin and Blankenstein, 2000; Zhang et al., 2008). However, since nearly all cells in
the host express functional IFN receptors, it remains unclear which host cells need to
respond to IFN in order to develop host protective tumor immunity. In fact, this question
has led to considerable disagreement within the field as to the immune versus nonimmune mechanisms underlying tumor rejection. Some have suggested that lymphocytes
are the critical targets of IFN owing to its capacity to polarize the T cell response to
Th1/CTL (Knutson and Disis, 2005) and to inhibit the capacity of regulatory T cells
(Tregs) to establish an immunosuppressive tumor microenvironment (Sakaguchi et al.,
2008). Others have suggested that IFN works to activate macrophages either inducing in
them the capacity to nonspecifically kill tumor cells (Schreiber, 1984) or to form
granulomas (Schuler et al., 2003) that restrict the access of carcinogens to normal cells.
Still others have suggested that IFN inhibits angiogenesis either directly or indirectly via
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inducing chemokines with potential angiostatic activity such as CXCL-9, -10, and -11
thereby causing tumor starvation and death (Qin et al., 2003). This argument has
remained unresolved because it has not been possible to inactivate IFN responsiveness
in individual tissues to define their specific roles in the rejection process. However, the
recent results of bone marrow chimera experiments indicate that rejection of unedited
MCA sarcomas requires IFN sensitivity at the level of both hematopoietic and nonhematopoietic host cellular compartments (Diamond et al., 2011). This observation has
led us to form the hypothesis that immune elimination of developing tumors requires a
coordinated multicellular response orchestrated by IFN’s effects on several different
cellular populations including (but perhaps not limited to) regulatory T cells and
endothelial cells.
For example, after breeding Ifngr1f/f mice with Foxp3-cre mice which will
selectively delete Ifngr1 in regulatory T cells , we can test whether lacking IFN
responsiveness in the Treg compartment should display heightened immunosuppressive
capacity because the IFN produced during the anti-bacterial and tumor response cannot
control Tregs. In collaboration with Dr. Hiroshi Shiku (Mie University, Japan), we
identified that IFN production by CD8+ T cells abrogates the generation/activation of
CD4+CD25+ Tregs in response to self-antigens that express Treg epitopes such as DNA Jlike 2 (Nishikawa et al., 2005). Immunization of WT BALB/c mice with DNA encoding
DNA J-like 2 resulted in enhanced pulmonary metastases following intravenous
challenge with syngeneic CMS-5 tumor cells. This protocol also resulted in accelerated
primary tumor development after MCA treatment due to the expansion of Treg in the
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immunized hosts. When the plasmid encoding DNA J-like 2 was co-injected with one
encoding a strong CD8+ T cell epitope (9m) that rapidly induces IFN, Treg were unable
to suppress proliferating T cells and there was a marked reduction in pulmonary
metastases and MCA-induced sarcoma formation. On the other hand, a role for IFN in
maintaining Treg homeostasis and function has been noted by others using a model of
anti-CD40 induced inflammation (Koch et al., 2009). This study could develop a
contradictory prediction to the previously stated hypothesis—that introduction of IFN
insensitivity into Tregs should reduce their function/homeostasis and thereby induce
heightened anti-bacterial/ tumor potential in Foxp3-cre+Ifngr1f/f mice.
The ability of IFN to inhibit tumor angiogenesis has been well documented by
others and has also been confirmed in our MCA sarcoma transplantation model. However,
to date no experiments have been forthcoming to distinguish between the possibilities
that IFN-induced angiostasis causes tumor rejection or is merely a by-product of the
rejection process. In addition, uncertainty remains as to the ultimate effectors of the
angiostatic response. IFN has certainly been shown to have direct antiproliferative
effects on endothelial cells (Ruegg et al., 1998). Some have proposed that production of
IFN induced chemokines, specifically CXCL-9, -10 and/or -11, is a key event in the
tumor rejection process due to their putative capacities to inhibit tumor angiogenesis
(Dufour et al., 2002; Melter et al., 2001; Pertl et al., 2001; Sauty et al., 2001). To test
whether this mechanism was relevant to MCA sarcoma rejection, our lab generated a
hamster mAb (CXCR3-173) specific for murine CXCR3 that blocks chemokine binding
in vitro and in vivo (Uppaluri et al., 2008). Using tumor transplantation approaches, we
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could not show inhibitory activity of CXCR3-173 on rejection of over unedited MCA
sarcomas (Uppaluri and Schreiber, unpublished). In follow-up studies we also found that
unedited sarcomas were rejected by CXCR3-/- mice in a manner similar to that observed
with WT mice. Finally, we compared susceptibility to MCA tumorigenesis between WT
and CXCR3-/- mice and again noted no differences. Thus our data strongly suggest that
tumor rejection is not related to the action of CXCR3 chemokines. Nevertheless, these
results do not rule out a direct angiostatic role for IFN in the rejection process (Qin and
Blankenstein, 2000). Taken together these data suggests that angiostasis may be a direct
function of IFN produced during the anti-tumor immune response but still does not
answer the question of whether this function leads to tumor rejection. For this reason,
generating mice that lack the capacity to respond to IFN only in the endothelial
compartment is extremely important and exciting. VE-cadherin-creERT2 can be used to
get an endothelial cell specific deletion of Ifngr1 (Monvoisin et al., 2006).
As shown above, the use of the Ifngr1f/f mice can be easily extended to explore
the roles of IFN on the selected tissues/cell types in various bacterial infection models
depending on which tissue-specific cre mice are chosen. Additionally, because the mice
are on a homogeneous background they can be utilized in tumor immunology,
autoimmunity models, and even transplantation model. By defining the specific targets of
IFN we will obtain new levels of understanding of host responses to various
immunological stimuli that may facilitate the development of new targeted treatments to
direct the specificity of IFN-dependent immunological processes into controlling
pathological diseases.
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Figure 36. The proposed model for the initiating events of anti-Listeria responses.
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Table 1: Current breeding status of mice with tissue-specific deletion of Ifngr1
Tissue-specific Ifngr1 KO mice

Tissue specificity

Current status

Vav-icre x Ifngr1f/f

All hematopoietic cells

Completed

Itgax-cre x Ifngr1f/f

Dendritic cells

Completed

LysM-cre x Ifngr1f/f

Macrophages, PMNs

Completed

NKp46-cre x Ifngr1f/f

NK/NKT cells

Completed

T cells

completed

Endothelial cells

completed

Regulatory T cells

In process

f/f

CD4-cre x Ifngr1
T2

VE-cadherin-creER x Ifngr1
f/f

Foxp3-GFP-cre x Ifngr1

f/f
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Figure 37. CD4-cre+Ifngr1f/f has no IFNGR1 in T cells
IFNGR1 expression was measured using flow cytometry in CD4-cre+Ifngr1f/f mice. The
spleens and PBLs from Ifngr1f/f, CD4-cre+Ifngr1f/f, and Ifngr1WU-/- were harvested and
stained with either biotinylated anti-IFNGR1 mAb or Isotype Ab with various lineage
markers (Figure 1).
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